Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2009

Open Access 01-12-2009 | Review

A comprehensive overview of radioguided surgery using gamma detection probe technology

Published in: World Journal of Surgical Oncology | Issue 1/2009

Login to get access

Abstract

The concept of radioguided surgery, which was first developed some 60 years ago, involves the use of a radiation detection probe system for the intraoperative detection of radionuclides. The use of gamma detection probe technology in radioguided surgery has tremendously expanded and has evolved into what is now considered an established discipline within the practice of surgery, revolutionizing the surgical management of many malignancies, including breast cancer, melanoma, and colorectal cancer, as well as the surgical management of parathyroid disease. The impact of radioguided surgery on the surgical management of cancer patients includes providing vital and real-time information to the surgeon regarding the location and extent of disease, as well as regarding the assessment of surgical resection margins. Additionally, it has allowed the surgeon to minimize the surgical invasiveness of many diagnostic and therapeutic procedures, while still maintaining maximum benefit to the cancer patient. In the current review, we have attempted to comprehensively evaluate the history, technical aspects, and clinical applications of radioguided surgery using gamma detection probe technology.
Literature
1.
Selverstone B, Sweet WH, Robinson CV: The clinical use of radioactive phosphorus in the surgery of brain tumors. Ann Surg. 1949, 130: 643-651.PubMedCentral
2.
Geiger H, Müller W: Elektronenzählrohr zur messung schwächster aktivitäten. Naturwissenschaften. 1928, 16: 617-618.
3.
Harris CC, Bigelow RR, Francis JE, Kelly GG, Bell PR: A Csi(Ti)-crystal surgical scintillation probe. Nucleonics. 1956, 14: 102-108.
4.
Woolfenden JM, Barber HB: Radiation detector probes for tumor localization using tumor-seeking radioactive tracers. AJR Am J Roentgenol. 1989, 153: 35-39.PubMed
5.
Schneebaum S, Even-Sapir E, Cohen M, Shacham-Lehrman H, Gat A, Brazovsky E, Livshitz G, Stadler J, Skornick Y: Clinical applications of gamma-detection probes-radioguided surgery. Eur J Nucl Med. 1999, 26: S26-S35.PubMed
6.
Barber HB, Barrett HH, Hickernell TS, Kwo DP, Woolfenden JM, Entine G, Ortale Baccash C: Comparison of NaI(Tl), CdTe, and HgI2 surgical probes: physical characterization. Med Phys. 1991, 18: 373-381.PubMed
7.
Kwo DP, Barber HB, Barrett HH, Hickernell TS, Woolfenden JM: Comparison of NaI(T1), CdTe, and HgI2 surgical probes: effect of scatter compensation on probe performance. Med Phys. 1991, 18: 382-389.PubMed
8.
Thurston MO: Development of the gamma-detecting probe for radioimmunoguided surgery. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 41-65. 1
9.
Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S: Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med. 1998, 25: 1224-1231.PubMed
10.
Hoffman EJ, Tornai MP, Janecek M, Patt BE, Iwanczyk JS: Intraoperative probes and imaging probes. Eur J Nucl Med. 1999, 26: 913-35.PubMed
11.
Zanzonico P, Heller S: The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med. 2000, 30: 33-48.PubMed
12.
Ricard M: Intraoperative detection of radiolabeled compounds using a hand held gamma probe. Nucl Instrum Meth Phys Res A. 2001, 458: 26-33.
13.
Zanzonico P: The intraoperative gamma probe: design, operation, and safety. Sentinel Lymph Node Biopsy. Edited by: Cody HS. 2002, London: Informa Health Care, 45-68. 1
14.
15.
Mariani G, Vaiano A, Nibale O, Rubello D: Is the "ideal" gamma-probe for intraoperative radioguided surgery conceivable?. J Nucl Med. 2005, 46: 388-90.PubMed
16.
Moffat FL: Targeting gold at the end of the rainbow: surgical gamma probes in the 21st century. J Surg Oncol. 2007, 96: 286-289.PubMed
17.
Sarikaya I, Sarikaya A, Reba RC: Gamma probes and their use in tumor detection in colorectal cancer. Int Semin Surg Oncol. 2008, 5: 25-PubMedCentralPubMed
18.
Daghighian F, Mazziotta JC, Hoffman EJ, Shenderov P, Eshaghian B, Siegel S, Phelps ME: Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery. Med Phys. 1994, 21: 153-157.PubMed
19.
Raylman RR, Wahl RL: A fiber-optically coupled positron-sensitive surgical probe. J Nucl Med. 1994, 35: 909-913.PubMed
20.
Raylman RR, Wahl RL: Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes. Med Phys. 1996, 23: 1889-1895.PubMed
21.
Raylman RR: A solid-state intraoperative beta probe system. IEEE Trans Nucl Sci. 2000, 47: 1696-1703.
22.
Yamamoto S, Matsumoto K, Sakamoto S, Tarutani K, Minato K, Senda M: An intra-operative positron probe with background rejection capability for FDG-guided surgery. Ann Nucl Med. 2005, 19: 23-28.PubMed
23.
Yamamoto S, Higashi T, Matsumoto K, Senda M: Development of a positron-imaging detector with background rejection capability. Ann Nucl Med. 2006, 20: 655-662.PubMed
24.
25.
26.
Hinkle GH, Laven DL: Radionucleotides. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 29-39. 1
27.
28.
Sergides IG, Austin RC, Winslet MC: Radioimmunodetection: technical problems and methods of improvement. Eur J Surg Oncol. 1999, 25: 529-539.PubMed
29.
Strong VE, Humm J, Russo P, Jungbluth A, Wong WD, Daghighian F, Old L, Fong Y, Larson SM: A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes. Surg Endosc. 2008, 22: 386-391.PubMed
30.
Nieroda CA, Milenic DE, Colcher D, Schlom J: Monoclonal Antibodies for Use in Radioimmunoguided Surgery (RIGS). Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 7-27. 1
31.
Mitchell ACG, Juliano JO, Creager CB, Kocher CW: Disintegration of I124 and I123. Phys Rev. 1959, 113: 628-633.
32.
Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, Finn RD, Jordan K, Kalaigian H, Karp JS, Robeson WR, Larson SM: Quantitative imaging of iodine-124 with PET. J Nucl Med. 1996, 37: 1557-1562.PubMed
33.
34.
Rault E, Vandenberghe S, Van Holen R, De Beenhouwer J, Staelens S, Lemahieu I: Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131). Cancer Biother Radiopharm. 2007, 22: 423-430.PubMed
35.
Desai D, Arnold M, Saha S, Hinkle G, Soble D, Frye J, DePalatis L, Mantil J, Satter M, Martin E: Intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging. 1999, 2: 325-PubMed
36.
Desai DC, Arnold M, Saha S, Hinkle G, Soble D, Fry J, DePalatis LR, Mantil J, Satter M, Martin EW: Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging. 2000, 3: 189-196.PubMed
37.
Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW: 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res. 2001, 97: 9-13.PubMed
38.
Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F: Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res. 2001, 96: 120-126.PubMed
39.
Essner R, Daghighian F, Giuliano AE: Advances in FDG PET probes in surgical oncology. Cancer J. 2002, 8: 100-108.PubMed
40.
Carrera D, Fernandez A, Estrada J, Martin-Comin J, Gamez C: [Detection of occult malignant melanoma by 18F-FDG PET-CT and gamma probe]. Rev Esp Med Nucl. 2005, 24: 410-413. [Spanish]PubMed
41.
Franc BL, Mari C, Johnson D, Leong SP: The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med. 2005, 30: 787-791.PubMed
42.
Kraeber-Bodéré F, Cariou B, Curtet C, Bridji B, Rousseau C, Dravet F, Charbonnel B, Carnaille B, Le Néel JC, Mirallié E: Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases. Surgery. 2005, 138: 1176-1182.PubMed
43.
Gulec SA, Daghighian F, Essner R: PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery. Ann Surg Oncol. 2006,
44.
Meller B, Sommer K, Gerl J, von Hof K, Surowiec A, Richter E, Wollenberg B, Baehre M: High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer. Nuklearmedizin. 2006, 45: 153-159.PubMed
45.
Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D: PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol. 2007, 5: 65-PubMedCentralPubMed
46.
Gulec SA: PET probe-guided surgery. J Surg Oncol. 2007, 96: 353-357.PubMed
47.
Piert M, Burian M, Meisetschlager G, Stein HJ, Ziegler S, Nahrig J, Picchio M, Buck A, Siewert JR, Schwaiger M: Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging. 2007, 34: 1534-1544.PubMedCentralPubMed
48.
Piert M, Carey J, Clinthorne N: Probe-guided localization of cancer deposits using [(18)F]fluorodeoxyglucose. Q J Nucl Med Mol Imaging. 2008, 52: 37-49.PubMed
49.
Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin EW: Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future. J Surg Oncol. 2007, 96: 297-308.PubMed
50.
Sarikaya I, Povoski SP, Al-Saif OH, Kocak E, Bloomston M, Marsh S, Cao Z, Murrey DA, Zhang J, Hall NC, Knopp MV, Martin EW: Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. World J Surg Oncol. 2007, 5: 80-PubMedCentralPubMed
51.
Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW: Combined approach of perioperative 18 F-FDG PET/CT imaging and intraoperative 18 F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer. World J Surg Oncol. 2007, 5: 143-PubMedCentralPubMed
52.
Povoski SP, Hall NC, Martin EW, Walker MJ: Multimodality approach of perioperative 18 F-FDG PET/CT imaging, intraoperative 18 F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. World J Surg Oncol. 2008, 6: 1-PubMedCentralPubMed
53.
Cohn DE, Hall NC, Povoski SP, Seamon LG, Farrar WB, Martin EW: Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer. Gynecol Oncol. 2008, 110: 152-157.PubMed
54.
Moffatt-Bruce SD, Povoski SP, Sharif S, Hall NC, Ross P, Johnson MA, Martin EW: A novel approach to positron emission tomography in lung cancer. Ann Thorac Surg. 2008, 86: 1355-1357.PubMed
55.
Snyder SE, Kilbourne MR: Chemistry of fluorine-18 radiopharmaceuticals. Handbook of Raiopharmaceuticals: Radiochemistry and Applications. Edited by: Welch MJ, Redvanly CS. 2003, Hoboken: John Wiley and Sons, Ltd, 195-228. 1
56.
Fowler JS, Ido T: Design and synthesis of 2-deoxy-2-[18 F] fluoro-D-glucose (18 FDG). Handbook of Raiopharmaceuticals: Radiochemistry and Applications. Edited by: Welch MJ, Redvanly CS. 2003, Hoboken: John Wiley and Sons, Ltd, 307-322. 1
57.
Hinkle GH, Houchens DP, Sampsel J, Schneebaum S: The RIGS System Using Animal Models. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 67-80. 1
58.
Martin EW, Barnes JA, Thurston MO: Introduction: The RIGS Concept. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 1-6. 1
59.
Martin EW, Thurston MO: The use of monoclonal antibodies (MAbs) and the development of an intraoperative hand-held probe for cancer detection. Cancer Invest. 1996, 14: 560-571.PubMed
60.
Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975, 256: 495-497.PubMed
61.
Martin EW, Thurston MO: Intraoperative radioimmunodetection. Semin Surg Oncol. 1998, 15: 205-208.PubMed
62.
Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 1986, 46: 850-857.PubMed
63.
Sheer DG, Schlom J, Cooper HL: Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res. 1988, 48: 6811-6818.PubMed
64.
Colcher D, Milenic D, Roselli M, Raubitschek A, Yarranton G, King D, Adair J, Whittle N, Bodmer M, Schlom J: Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Cancer Res. 1989, 49: 1738-1745.PubMed
65.
Stramignoni D, Bowen R, Atkinson BF, Schlom J: Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer. 1983, 31: 543-552.PubMed
66.
Ohuchi N, Simpson JF, Colcher D, Schlom J: Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas. Int J Cancer. 1987, 40: 726-733.PubMed
67.
Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J: Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J Natl Cancer Inst. 1986, 76: 995-1006.PubMed
68.
Nuti M, Teramoto YA, Mariani-Costantini R, Hand PH, Colcher D, Schlom J: A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer. 1982, 29: 539-545.PubMed
69.
Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J: Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 1986, 46: 3118-3124.PubMed
70.
Colcher D, Hand PH, Nuti M, Schlom J: A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA. 1981, 78: 3199-3203.PubMedCentralPubMed
71.
Thor A, Viglione MJ, Muraro R, Ohuchi N, Schlom J, Gorstein F: Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynecol Pathol. 1987, 6: 235-247.PubMed
72.
Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P, Schlom J: Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res. 1988, 48: 4588-4596.PubMed
73.
Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J: Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res. 1988, 48: 4597-4603.PubMed
74.
Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, Martin EW: Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann Surg. 1992, 216: 627-632.PubMedCentralPubMed
75.
Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin EW: Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery. 1992, 112: 624-629.PubMed
76.
Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985, 45: 879-885.PubMed
77.
Colcher D, Milenic DE, Ferroni P, Carrasquillo JA, Reynolds JC, Roselli M, Larson M, Schlom J: In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. J Nucl Med. 1990, 3: 1133-1142.
78.
Mojzisik CM, Cook CH, Schneebaum S: Safety and Performance Factors in the Development and Clinical Use of the RIGS System. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Edited by: Martin EW. 1994, Austin: R.G. Landes Company, 81-105. 1
79.
Frödin JE, Lefvert AK, Mellstedt H: The clinical significance of HAMA in patients treated with mouse monoclonal antibodies. Cell Biophys. 1992, 21: 153-165.PubMed
80.
Gruber R, van Haarlem LJ, Warnaar SO, Holz E, Riethmüller G: The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A. Cancer Res. 2000, 60: 1921-1926.PubMed
81.
Kashmiri SV, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH: Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma. 1995, 14: 461-473.PubMed
82.
Xiao J, Horst S, Hinkle G, Cao X, Kocak E, Fang J, Young D, Khazaeli M, Agnese D, Sun D, Martin E: Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients. Cancer Biother Radiopharm. 2005, 20: 16-26.PubMed
83.
Slavin-Chiorini DC, Kashmiri SV, Lee HS, Milenic DE, Poole DJ, Bernon E, Schlom J, Hand PH: A CDR-grafted (humanized) domain-deleted antitumor antibody. Cancer Biother Radiopharm. 1997, 12: 305-316.PubMed
84.
Fang L, Holford NH, Hinkle G, Cao X, Xiao JJ, Bloomston M, Gibbs S, Saif OH, Dalton JT, Chan KK, Schlom J, Martin EW, Sun D: Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patients. J Clin Pharmacol. 2007, 47: 227-237.PubMed
85.
Muraro R, Wunderlich D, Thor A, Lundy J, Noguchi P, Cunningham R, Schlom J: Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 1985, 45: 5769-5780.PubMed
86.
Hammarström S: The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999, 9: 67-81.PubMed
87.
Goldenberg DM, Kim EE, DeLand FH, Bennett S, Primus FJ: Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res. 1980, 40: 2984-2992.PubMed
88.
Nap M, Hammarstrom M-L, Borer O, Hammarstrom S, Wagner C, Handt S, Schreyer M, Mach JP, Buchegget F, von Kleist S, Grunert F, Seguin P, Fuks A, Holm R, Lamerz R: Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res. 1992, 52: 2329-2339.PubMed
89.
Shi ZR, Tacha D, Itzkowitz SH: Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study. J Histochem Cytochem. 1994, 42: 1215-1219.PubMed
90.
Gu J, Zhao J, Li Z, Yang Z, Zhang J, Gao Z, Wang Y, Xu G: Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum. 2003, 46: 1659-1666.PubMed
91.
Dawson PM, Blair SD, Begent RH, Kelly AM, Boxer GM, Theodorou NA: The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer. Dis Colon Rectum. 1991, 34: 217-222.PubMed
92.
Goldenberg DM, Goldenberg H, Sharkey RM, Lee RE, Horowitz JA, Hall TC, Hansen HJ: In-vivo antibody imaging for the detection of human tumors. Cancer Treat Res. 1990, 51: 273-292.PubMed
93.
Goldenberg DM, Goldenberg H, Sharkey RM, Higginbotham-Ford E, Lee RE, Swayne LC, Burger KA, Tsai D, Horowitz JA, Hall TC, Pinsky CM, Hansen HJ: Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc. Cancer Res. 1990, 50: 909s-921s.PubMed
94.
Göttlinger HG, Funke I, Johnson JP, Gokel JM, Riethmüller G: The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer. 1986, 38: 47-53.PubMed
95.
Göttlinger H, Johnson J, Riethmüller G: Biochemical and epitope analysis of the 17-1A membrane antigen. Hybridoma. 1986, 5 (Suppl 1): S29-S37.PubMed
96.
Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO: Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol. 1994, 125: 437-446.PubMed
97.
Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976, 36: 4562-4569.PubMed
98.
Packeisen J, Kaup-Franzen C, Knieriem HJ: Detection of surface antigen 17-1A in breast and colorectal cancer. Hybridoma. 1999, 18: 37-40.PubMed
99.
Herlyn M, Steplewski Z, Herlyn D, Koprowski H: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA. 1979, 76: 1438-1442.PubMedCentralPubMed
100.
Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H: Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res. 1980, 40: 717-721.PubMed
101.
Martin EW, Tuttle SE, Rousseau M, Mojzisik CM, O'Dwyer PJ, Hinkle GH, Miller EA, Goodwin RA, Oredipe OA, Barth RF, Olsen JO, Houchens D, Jewell SD, Bucci DM, Adams D, Steplewski Z, Thurston MO: Radioimmunoguided surgery: intraoperative use of monoclonal antibody 17-1A in colorectal cancer. Hybridoma. 1986, 5 (Suppl 1): S97-S108.PubMed
102.
Paganelli G, Magnani P, Fazio F: Pretargeting of carcinomas with the avidin-biotin system. Int J Biol Markers. 1993, 8: 155-159.PubMed
103.
Gruaz-Guyon A, Janevik-Ivanovska E, Raguin O, De Labriolle-Vaylet C, Barbet J: Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy. Q J Nucl Med. 2001, 45: 201-206.PubMed
104.
105.
Breitz HB, Tyler A, Bjorn MJ, Lesley T, Weiden PL: Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy. Clin Nucl Med. 1997, 22: 615-620.PubMed
106.
Lechner P, Lind P, Snyder M, Haushofer H: Probe-guided surgery for colorectal cancer. Recent Results Cancer Res. 2000, 157: 273-280.PubMed
107.
Hladik P, Vizda J, Bedrna J, Simkovic D, Strnad L, Smejkal K, Voboril Z: Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma. Colorectal Dis. 2001, 3: 380-386.PubMed
108.
Abdel-Nabi H, Doerr RJ: Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients. Semin Nucl Med. 1993, 23: 99-113.PubMed
109.
Kuhn JA, Nochumson J: Operative probe scintimetry with indium and technetium for colorectal cancer. J Surg Oncol. 2007, 96: 290-296.PubMed
110.
Warburg O, Posener K, Negelein E: The metabolism of the carcinoma cell. The Mechanism of Tumors. Edited by: Warburg O. 1931, New York: Richard R. Smith, Inc, 129-169. 1
111.
Weber G: Enzymology of cancer cells. N Engl J Med. 1977, 296: 486-493.PubMed
112.
Merrall NW, Plevin R, Gould GW: Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal. 1993, 5: 667-675.PubMed
113.
Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Mazière B: FDG accumulation and tumor biology. Nucl Med Biol. 1998, 25: 317-322.PubMed
114.
Gambhir SS: Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002, 2: 683-693.PubMed
115.
Buck AK, Reske SN: Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?. J Nucl Med. 2004, 45: 461-463.PubMed
116.
Otsuka H, Graham M, Kubo A, Nishitani H: Clinical utility of FDG PET. J Med Invest. 2004, 51: 14-19.PubMed
117.
Otsuka H, Morita N, Yamashita K, Nishitani H: FDG-PET/CT for cancer management. J Med Invest. 2007, 54: 195-199.PubMed
118.
119.
ICRP, Publication 60: The 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991, 21 (1–3): 1-201.
120.
ICRP, Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection (Chapters 5 and 6). Ann ICRP. 2007, 37 (2–4): 81-123.
121.
Mojzisik C, Loesch J, Hinkle G, Petty L, Berens A, Thurston M, Martin E: An intraoperative assessment of radioactive contamination associated with radioimmunoguided surgery. Association of Operating Room Nurses, Atlanta, GA, April 7–12. 1991
122.
Stokkel MP, Boot IN, Smit JW: Personal dosimetry of the staff during treatment of neuroendocrine tumours with a high dose of Indium-111 Octreotide. Q J Nucl Med. 2002, 46: 331-335.PubMed
123.
Stratmann SL, McCarty TM, Kuhn JA: Radiation safety with breast sentinel node biopsy. Am J Surg. 1999, 178: 454-457.PubMed
124.
Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ: Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med. 2000, 27: 377-391.PubMed
125.
de Kanter AY, Arends PP, Eggermont AM, Wiggers T: Radiation protection for the sentinel node procedure in breast cancer. Eur J Surg Oncol. 2003, 29: 396-399.PubMed
126.
Sera T, Mohos G, Papos M, Osvay M, Varga J, Lazar M, Kiss E, Kapitany K, Dobozy A, Csernay L, Pavics L: Sentinel node detection in malignant melanoma patients: radiation safety considerations. Dermatol Surg. 2003, 29: 141-145.PubMed
127.
Klausen TL, Chakera AH, Friis E, Rank F, Hesse B, Holm S: Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging. 2005, 25: 196-202.PubMed
128.
Kojima T, Kumita S, Yamaguchi F, Mizumura S, Kitamura T, Kumazaki T, Teramoto A: Radio-guided brain tumorectomy using a gamma detecting probe and a mobile solid-state gamma camera. Surg Neurol. 2004, 61: 229-238. discussion 238PubMed
129.
Bekiş R, Celik P, Uysal B, Koçdor MA, Atila K, Saydam S, Harmancıoğlu O, Durak H: Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy. Eur Arch Otorhinolaryngol. 2008, 265: 1545-1548.PubMed
130.
Heckathorne E, Dimock C, Dahlbom M: Radiation dose to surgical staff from positron-emitter-based localization and radiosurgery of tumors. Health Phys. 2008, 95: 220-226.PubMed
131.
Andersen PA, Chakera AH, Klausen TL, Binderup T, Grossjohann HS, Friis E, Hansen CP, Schmidt G, Kjaer A, Hesse B: Radiation exposure to surgical staff during F-18-FDG-guided cancer surgery. Eur J Nucl Med Mol Imaging. 2008, 35: 624-629.PubMed
132.
Povoski SP, Sarikaya I, White WC, Marsh SG, Hall NC, Hinkle GH, Martin EW, Knopp MV: A comprehensive evaluation of occupational radiation exposure to intraoperative and perioperative personnel from 18 F-FDG radioguided surgical procedures. Eur J Nucl Med Mol Imaging. 2008, 35: 2026-2034.PubMed
133.
Burak WE, Agnese DM, Povoski SP: Advances in the surgical management of early stage invasive breast cancer. Curr Probl Surg. 2004, 41: 877-936.
134.
135.
Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993, 2: 335-339. discussion 340PubMed
136.
Wilhelm AJ, Mijnhout GS, Franssen EJF: Radiopharmaceuticals in sentinel lymph-node detection – an overview. Eur J Nucl Med. 1999, 26: S36-S42.PubMed
137.
McCarter MD, Yeung H, Yeh S, Fey J, Borgen PI, Cody HS: Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol. 2001, 8: 682-686.PubMed
138.
Ent van der FW, Kengen RA, Pol van der HA, Hoofwijk AG: Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol. 1999, 25: 24-29.PubMed
139.
Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KK: Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol. 2001, 8: 821-817.PubMed
140.
Gray RJ, Pockaj BA, Roarke MC: Injection of (99m)Tc-labeled sulfur colloid the day before operation for breast cancer sentinel lymph node mapping is as successful as injection the day of operation. Am J Surg. 2004, 188: 685-689.PubMed
141.
Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, Carson WE, Yee LD, Agnese DM, Pozderac RV, Hall NC, Farrar WB: Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006, 13: 1412-1421.PubMed
142.
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM: Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001, 192: 684-689. discussion 689–691PubMed
143.
Martin RC, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study: Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005, 241: 1005-1012. discussion 1012–1015PubMedCentralPubMed
144.
Povoski SP, Young DC, Walker MJ, Carson WE, Yee LD, Agnese DM, Farrar WB: Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol. 2007, 5: 18-PubMedCentralPubMed
145.
Woznick A, Franco M, Bendick P, Benitez PR: Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?. Am J Surg. 2006, 191: 330-333.PubMed
146.
Wada N, Sakemura N, Imoto S, Hasebe T, Ochiai A, Moriyama N: Sentinel node biopsy in primary breast cancer: radioactive detection and metastatic disease. Eur J Surg Oncol. 2007, 33: 691-695.PubMed
147.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP, Wolmark N: National Surgical Adjuvant Breast and Bowel Project: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007, 8: 881-888.PubMed
148.
Nieroda CA, Mojzisik C, Sardi A, Farrar WB, Hinkle G, Siddiqi MA, Ferrara PJ, James A, Schlom J, Thurston MO, Martin EW: Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3. Surg Gynecol Obstet. 1989, 169: 35-40.PubMed
149.
Martin EW, Mojzisik CM, Hinkle GH, Sampsel J, Siddiqi M, Tuttle SE, Sickle-Santanello B, Colcher D, Thurston MO, Bell J, Farrar WB, Schlom J: Radioimmunoguided surgery using monoclonal antibody. Am J Surg. 1988, 156: 386-392.PubMed
150.
Percivale P, Bertoglio S, Meszaros P, Canavese G, Cafiero F, Gipponi M, Campora E, Gasco M, Badellino F: Radioimmunoguided surgery after primary treatment of locally advanced breast cancer. J Clin Oncol. 1996, 14: 1599-1603.PubMed
151.
Badellino F, Bertoglio S, Mariani G, Meszaros P, Canavese G, Percivale P: Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer. Semin Surg Oncol. 1998, 15: 245-248.PubMed
152.
Burak WE, DePalatis L, Mosic JL, Soble D, Hinkle G, Hitchcock CL: Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 FAB: a pilot study. Tumori. 2001, 87: 142-146.PubMed
153.
Gennari R, Galimberti V, De Cicco C, Zurrida S, Zerwes F, Pigatto F, Luini A, Paganelli G, Veronesi U: Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. J Am Coll Surg. 2000, 190: 692-698. discussion 698–699PubMed
154.
Luini A, Zurrida S, Paganelli G, Galimberti V, Sacchini V, Monti S, Veronesi P, Viale G, Veronesi U: Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg. 1999, 86: 522-525.PubMed
155.
Feggi L, Basaglia E, Corcione S, Querzoli P, Soliani G, Ascanelli S, Prandini N, Bergossi L, Carcoforo P: An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation. Eur J Nucl Med. 2001, 28: 1589-1596.PubMed
156.
Gray RJ, Giuliano R, Dauway EL, Cox CE, Reintgen DS: Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). Am J Surg. 2001, 182: 404-406.PubMed
157.
Tanis PJ, Deurloo EE, Valdés Olmos RA, Rutgers EJ, Nieweg OE, Besnard AP, Kroon BB: Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol. 2001, 8: 850-855.PubMed
158.
De Cicco C, Pizzamiglio M, Trifiro G, Luini A, Ferrari M, Prisco G, Galimberti V, Cassano E, Viale G, Intra M, Veronesi P, Paganelli G: Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med. 2002, 46: 145-151.PubMed
159.
Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC: Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004, 188: 377-380.PubMed
160.
Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD: Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg. 2004, 91: 1575-1577.PubMed
161.
Zgajnar J, Hocevar M, Frkovic-Grazio S, Hertl K, Schweiger E, Besic N: Radioguided occult lesion localization (ROLL) of the nonpalpable breast lesions. Neoplasma. 2004, 51: 385-389.PubMed
162.
Patel A, Pain SJ, Britton P, Sinnatamby R, Warren R, Bobrow L, Barber RW, Peters AM, Purushotham AD: Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer. Eur J Surg Oncol. 2004, 30: 918-923.PubMed
163.
Ronka R, Krogerus L, Leppanen E, von Smitten K, Leidenius M: Radio-guided occult lesion localization in patients undergoing breast-conserving surgery and sentinel node biopsy. Am J Surg. 2004, 187: 491-496.PubMed
164.
Audisio RA, Nadeem R, Harris O, Desmond S, Thind R, Chagla LS: Radioguided occult lesion localisation (ROLL) is available in the UK for impalpable breast lesions. Ann R Coll Surg Engl. 2005, 87: 92-95.PubMedCentralPubMed
165.
Thind CR, Desmond S, Harris O, Nadeem R, Chagla LS, Audisio RA: Radio-guided localization of clinically occult breast lesions (ROLL): a DGH experience. Clin Radiol. 2005, 60: 681-686.PubMed
166.
Nadeem R, Chagla LS, Harris O, Desmond S, Thind R, Titterrell C, Audisio RA: Occult breast lesions: A comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). Breast. 2005, 14: 283-289.PubMed
167.
Duarte GM, dos Santos CC, Torresan RZ, Alvarenga M, Telles GH, Bianchessi ST, Caserta N, Segala SR, Lopes de Lima Mda C, de Camargo Etchebehere EC, Camargo EE: Radioguided surgery using intravenous 99mTc sestamibi associated with breast magnetic resonance imaging for guidance of breast cancer resection. Breast J. 2006, 12: 202-207.PubMed
168.
Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, Fernandez-Rodriguez J, Rotmensz N, Latronico A, Berrettini A, Mauri M, Machado L, Luini A, Paganelli G: Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007, 14: 2928-2931.PubMed
169.
Medina-Franco H, Abarca-Perez L, Ulloa-Gomez JL, Romero C: Radioguided localization of clinically occult breast lesions (ROLL): a pilot study. Breast J. 2007, 13: 401-405.PubMed
170.
van Rijk MC, Tanis PJ, Nieweg OE, Loo CE, Olmos RA, Oldenburg HS, Rutgers EJ, Hoefnagel CA, Kroon BB: Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer. Ann Surg Oncol. 2007, 14: 627-632.PubMed
171.
Barros AC, Barros MA, Andrade FE, Mori LJ, Costa PA, Sheng PY, Pelizon CH: Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma. Ann Surg Oncol. 2007, 14: 1472-1477.PubMed
172.
Panareo S, Carcoforo P, Lanzara S, Corcione S, Bagatin E, Casali M, Costanzo A, Basaglia E, Feggi LM: Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures. Breast. 2007, 17: 111-114.PubMed
173.
Machado RH, Oliveira AC, Rocha AC, Landesmann MC, Martins FP, Lopes SA, Gutfilen B, da Fonseca LM: Radioguided occult lesion localization (ROLL) and excision of breast lesions using technetium-99m-macroaggregate albumin and air injection control. J Exp Clin Cancer Res. 2007, 26: 323-327.PubMed
174.
Paredes P, Vidal-Sicart S, Zanón G, Roé N, Rubí S, Lafuente S, Pavía J, Pons F: Radioguided occult lesion localisation in breast cancer using an intraoperative portable gamma camera: first results. Eur J Nucl Med Mol Imaging. 2007, 35: 230-235.PubMed
175.
Medina-Franco H, Abarca-Pérez L, García-Alvarez MN, Ulloa-Gómez JL, Romero-Trejo C, Sepúlveda-Méndez J: Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J Surg Oncol. 2008, 97: 108-111.PubMed
176.
Ploeg van der IM, Hobbelink M, Bosch van den MA, Mali WP, Rinkes IH, van Hillegersberg R: Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: A review of the relevant literature. Eur J Surg Oncol. 2008, 34: 1-5.PubMed
177.
Lavoué V, Nos C, Clough KB, Baghaie F, Zerbib E, Poulet B, Lefrère Belda MA, Ducellier A, Lecuru F: Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008, 15: 2556-2561.PubMed
178.
Van Esser S, Hobbelink M, Ploeg Van der IM, Mali WP, Van Diest PJ, Borel Rinkes IH, Van Hillegersberg R: Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. J Surg Oncol. 2008, 98: 526-529.PubMed
179.
Moreno M, Wiltgen JE, Bodanese B, Schmitt RL, Gutfilen B, da Fonseca LM: Radioguided breast surgery for occult lesion localization – correlation between two methods. J Exp Clin Cancer Res. 2008, 27: 29-PubMedCentralPubMed
180.
Sarlos D, Frey LD, Haueisen H, Landmann G, Kots LA, Schaer G: Radioguided occult lesion localization (ROLL) for treatment and diagnosis of malignant and premalignant breast lesions combined with sentinel node biopsy: A prospective clinical trial with 100 patients. Eur J Surg Oncol. 2008,
181.
Ramesh HS, Anguille S, Chagla LS, Harris O, Desmond S, Thind R, Audisio RA: Recurrence after ROLL lumpectomy for invasive breast cancer. Breast. 2008, 17: 637-639.PubMed
182.
van Esser S, Hobbelink MG, Peeters PH, Buskens E, Ploeg van der IM, Mali WP, Borel Rinkes IH, van Hillegersberg R: The efficacy of 'Radio guided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized clinical trial – ROLL study. BMC Surg. 2008, 8: 9-PubMedCentralPubMed
183.
Cuntz MC, Levine EA, O'Dorisio TM, Watson JC, Wray DA, Espenan GD, McKnight C, Meier JR, Weber LJ, Mera R, O'Dorisio MS, Woltering EA: Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer. Ann Surg Oncol. 1999, 6: 367-372.PubMed
184.
Duarte GM, Cabello C, Torresan RZ, Alvarenga M, Telles GH, Bianchessi ST, Caserta N, Segala SR, de Lima MC, Etchebehere EC, Camargo EE: Radioguided Intraoperative Margins Evaluation (RIME): Preliminary results of a new technique to aid breast cancer resection. Eur J Surg Oncol. 2007, 33: 1150-1157.PubMed
185.
186.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992, 127: 392-399.PubMed
187.
Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH: Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993, 34: 1435-1440.PubMed
188.
Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN: Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol. 1993, 2: 303-308.PubMed
189.
Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS: Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996, 223: 217-224.PubMedCentralPubMed
190.
Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA: The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996, 22: 715-720.PubMed
191.
Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ: Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg. 1997, 21: 788-792. discussion 793PubMed
192.
Gershenwald JE, Tseng CH, Thompson W, Mansfield PF, Lee JE, Bouvet M, Lee JJ, Ross MI: Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery. 1998, 124: 203-210.PubMed
193.
Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999, 230: 453-463. discussion 463–465PubMedCentralPubMed
194.
Landi G, Polverelli M, Moscatelli G, Morelli R, Landi C, Fiscelli O, Erbazzi A: Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases. J Eur Acad Dermatol Venereol. 2000, 14: 35-45.PubMed
195.
Pijpers R, Borgstein PJ, Teule GJ, Meijer S: Vital dye and radiolabelled colloids – complement or alternative?. Recent Results Cancer Res. 2000, 157: 130-137.PubMed
196.
Povoski SP, Choudry UH, Dauway EL, Rassekh CH, Ducatman BS: Sentinel lymph node mapping and biopsy for malignant melanoma at a rural-based university medical center. W V Med J. 2002, 98: 194-197.PubMed
197.
Ariyan S, Ariyan C, Farber LR, Fischer DS, Flynn SD, Truini C: Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J Am Coll Surg. 2004, 198: 924-932.PubMed
198.
Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR: Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res. 2004, 14: 521-526.PubMed
199.
Krag D, Harlow S, Weaver D, Ashikaga T: Technique of sentinel node resection in melanoma and breast cancer: probe-guided surgery and lymphatic mapping. Eur J Surg Oncol. 1998, 24: 89-93.PubMed
200.
Kelley MC, Ollila DW, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol. 1998, 14: 283-290.PubMed
201.
Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, Pijpers R, Morton DL: The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer. 2000, 89: 236-241.PubMed
202.
Clary BM, Brady MS, Lewis JJ, Coit DG: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg. 2001, 233: 250-258.PubMedCentralPubMed
203.
Intenzo CM, Kim SM, Patel JI, Lin HC, Kairys JC: Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping. Radiographics. 2002, 22: 491-502.PubMed
204.
Perrott RE, Glass LF, Reintgen DS, Fenske NA: Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol. 2003, 49: 567-588.PubMed
205.
Landry CS, McMasters KM, Scoggins CR: The evolution of the management of regional lymph nodes in melanoma. J Surg Oncol. 2007, 96: 316-321.PubMed
206.
Amersi F, Morton DL: The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg. 2007, 41: 241-256.PubMedCentralPubMed
207.
Porter GA, Ross MI, Berman RS, Lee JE, Mansfield PF, Gershenwald JE: Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol. 2000, 7: 256-261.PubMed
208.
Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB: Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg. 2000, 87: 484-489.PubMed
209.
Jacobs IA, Chang CK, Salti GI: Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy. J Am Acad Dermatol. 2003, 49: 615-619.PubMed
210.
Leong SP, Morita ET, Südmeyer M, Chang J, Shen D, Achtem TA, Allen RE, Kashani-Sabet M: Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med. 2005, 30: 150-158.PubMed
211.
Jimenez RE, Panageas K, Busam KJ, Brady MS: Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol. 2005, 23: 518-524.PubMed
212.
McHugh JB, Su L, Griffith KA, Schwartz JL, Wong SL, Cimmino V, Chang AE, Johnson TM, Sabel MS: Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol. 2006, 13: 1216-1223.PubMed
213.
Vucetić B, Andreja Rogan S, Balenović A, Ivkić M, Situm M, Hudorović N, Kusić Z: The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma. Wien Klin Wochenschr. 2006, 118: 286-293.PubMed
214.
Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR, Sunbelt Melanoma Trial: Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg. 2008, 143: 632-637. discussion 637–638PubMed
215.
Wong JH, Truelove K, Ko P, Coel MN: Localization and resection of an in transit sentinel lymph node by use of lymphoscintigraphy, intraoperative lymphatic mapping, and a hand-held gamma probe. Surgery. 1996, 120: 114-116.PubMed
216.
Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, Shaw HM: Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000, 135: 1168-1172.PubMed
217.
Thelmo MC, Morita ET, Treseler PA, Nguyen LH, Allen RE, Sagebiel RW, Kashani-Sabet M, Leong SP: Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma. Ann Surg Oncol. 2001, 8: 444-448.PubMed
218.
McMasters KM, Chao C, Wong SL, Wrightson WR, Ross MI, Reintgen DS, Noyes RD, Cerrito PB, Edwards MJ, Sunbelt Melanoma Trial Group: Interval sentinel lymph nodes in melanoma. Arch Surg. 2002, 137: 543-547.PubMed
219.
Vidal-Sicart S, Pons F, Fuertes S, Vilalta A, Rull R, Puig S, Palou JM, Ortega M, Castel T: Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?. Eur J Nucl Med Mol Imaging. 2004, 31: 945-949.PubMed
220.
Nathanson SD: Will the true sentinel node please stand?. Ann Surg Oncol. 1999, 6: 514-516.PubMed
221.
McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN, Noyes RD, Viar V, Cerrito PB, Edwards MJ: Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?. Ann Surg Oncol. 2001, 8: 192-197.PubMed
222.
Carlson GW, Murray DR, Thourani V, Hestley A, Cohen C: The definition of the sentinel lymph node in melanoma based on radioactive counts. Ann Surg Oncol. 2002, 9: 929-933.PubMed
223.
Jacobs IA, Chang CK, DasGupta TK, Salti G: High isotope counts and sentinel node positivity in patients with melanoma. Arch Surg. 2003, 138: 63-66. discussion 67PubMed
224.
Kroon HM, Lowe L, Wong S, Fullen D, Su L, Cimmino V, Chang AE, Johnson T, Sabel MS: What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma. J Surg Oncol. 2007, 95: 623-628.PubMed
225.
Emery RE, Stevens JS, Nance RW, Corless CL, Vetto JT: Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes. Am J Surg. 2007, 193: 618-622. discussion 622PubMed
226.
Esmaeli B: Sentinel lymph node mapping for patients with cutaneous and conjunctival malignant melanoma. Ophthal Plast Reconstr Surg. 2000, 16: 170-172.PubMed
227.
Wilson MW, Fleming JC, Fleming RM, Haik BG: Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthal Plast Reconstr Surg. 2001, 17: 338-344. discussion 344–345PubMed
228.
Esmaeli B, Eicher S, Popp J, Delpassand E, Prieto VG, Gershenwald JE: Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg. 2001, 17: 436-442.PubMed
229.
Amato M, Esmaeli B, Ahmadi MA, Tehrani MH, Gershenwald J, Ross M, Holds J, Delpassand E: Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg. 2003, 19: 102-106.PubMed
230.
Esmaeli B, Reifler D, Prieto VG, Amir Ahmadi M, Hidaji L, Delpassand E, Ross MI: Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol. 2003, 121: 1779-1783.PubMed
231.
Nijhawan N, Ross MI, Diba R, Ahmadi MA, Esmaeli B: Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg. 2004, 20: 291-295.PubMed
232.
Baroody M, Holds JB, Kokoska MS, Boyd J: Conjunctival melanoma metastasis diagnosed by sentinel lymph node biopsy. Am J Ophthalmol. 2004, 137: 1147-1149.PubMed
233.
Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B: Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg. 2007, 133: 820-82.PubMed
234.
Schwarz KA, Davison SP, Crane AE: Sentinel lymph node biopsy in the setting of conjunctival melanoma. Plast Reconstr Surg. 2008, 121: 212e-213e.PubMed
235.
de Hullu JA, Hollema H, Hoekstra HJ, Piers DA, Mourits MJ, Aalders JG, Zee van der AG: Vulvar melanoma: is there a role for sentinel lymph node biopsy?. Cancer. 2002, 94: 486-491.PubMed
236.
Abramova L, Parekh J, Irvin WP, Rice LW, Taylor PT, Anderson WA, Slingluff CL: Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol. 2002, 9: 840-846.PubMed
237.
Wechter ME, Gruber SB, Haefner HK, Lowe L, Schwartz JL, Reynolds KR, Johnston CM, Johnson TM: Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol. 2004, 50: 554-562.PubMed
238.
Dhar KK, DAS N, Brinkman DA, Beynon JL, Woolas RP: Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. Int J Gynecol Cancer. 2007, 17: 720-723.PubMed
239.
Migliano E, Monarca C, Mariani L, Tedesco M, Bucher S: Vulvar primitive melanoma and sentinel lymph node: case report. Eur J Gynaecol Oncol. 2007, 28: 229-232.PubMed
240.
Ayhan A, Celik H, Dursun P: Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature. World J Surg Oncol. 2008, 6: 53-PubMedCentralPubMed
241.
Rodier JF, Janser JC, David E, Routiot T, Ott G: Radiopharmaceutical-guided surgery in primary malignant melanoma of the vagina. Gynecol Oncol. 1999, 75: 308-309.PubMed
242.
Descheemaeker V, Garin E, Morcel K, Lesimple T, Burtin F, Levêque J: Radioisotopic location of the sentinel node in vaginal mucous melanoma before laparoscopic sampling. Surg Laparosc Endosc Percutan Tech. 2008, 18: 195-196.PubMed
243.
Tien HY, McMasters KM, Edwards MJ, Chao C: Sentinel lymph node metastasis in anal melanoma: a case report. Int J Gastrointest Cancer. 2002, 2: 53-56.
244.
Bobin JY, Gérard JP, Chapet O, Romestaing P, Isaac S: [Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation]. Cancer Radiother. 2003, 7 (Suppl 1): 85s-90s. [French]PubMed
245.
Olsha O, Mintz A, Gimon Z, Gold Deutch R, Rabin I, Halevy A, Reissman P: Anal melanoma in the era of sentinel lymph node mapping: a diagnostic and therapeutic challenge. Tech Coloproctol. 2005, 9: 60-62.PubMed
246.
Sanli Y, Turkmen C, Kurul S, Taş F, Mudun A, Cantez S: Sentinel lymph node biopsy for the staging of anal melanoma: report of two cases. Ann Nucl Med. 2006, 20: 629-631.PubMed
247.
Duport C, Tiffet O, Perrot JL, Prévot N, Rey Y, Cambazard F: [Sentinel node mapping in anorectal melanoma]. Ann Chir. 2006, 131: 550-552. [French]PubMed
248.
Mariolis-Sapsakos T, Malamitsi J, Yakoumakis E, Orfanos F: Is sentinel node mapping useful in anorectal melanoma?. Hell J Nucl Med. 2008, 11: 39-42.PubMed
249.
Argenyi EE, Dogan AS, Urdaneta LF, Ponto LL, Hichwa RD, Watkins GL: Detection of unsuspected metastasis in a melanoma patient with positron emission tomography. Clin Nucl Med. 1995, 20: 744-747.PubMed
250.
Steinert HC, Huch Böni RA, Buck A, Böni R, Berthold T, Marincek B, Burg G, von Schulthess GK: Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995, 195: 705-709.PubMed
251.
Damian DL, Fulham MJ, Thompson E, Thompson JF: Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res. 1996, 6: 325-329.PubMed
252.
Brady MS, Akhurst T, Spanknebel K, Hilton S, Gonen M, Patel A, Larson S: Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Ann Surg Oncol. 2006, 13: 525-532.PubMed
253.
Reinhardt MJ, Joe AY, Jaeger U, Huber A, Matthies A, Bucerius J, Roedel R, Strunk H, Bieber T, Biersack HJ, Tüting T: Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol. 2006, 24: 1178-1187.PubMed
254.
Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL: Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol. 2002, 20: 4549-4554.PubMed
255.
256.
Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, Wong SL: Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007, 110: 1-12.PubMed
257.
Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, Glass LF: Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997, 4: 389-395.PubMed
258.
Ames SE, Krag DN, Brady MS: Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol. 1998, 67: 251-254.PubMed
259.
Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, Sostrin S, Turner RR, Morton DL: Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am. 1998, 4: 351-358.PubMed
260.
Hill AD, Brady MS, Coit DG: Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999, 86: 518-521.PubMed
261.
Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ: Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg. 1999, 42: 679-682.PubMed
262.
Zeitouni NC, Cheney RT, Delacure MD: Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg. 2000, 26: 12-18.PubMed
263.
Kurul S, Mudun A, Aksakal N, Aygen M: Lymphatic mapping for Merkel cell carcinoma. Plast Reconstr Surg. 2000, 105: 680-683.PubMed
264.
Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG: Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer. 2001, 92: 1650-1655.PubMed
265.
Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH: Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol. 2001, 45: 303-308.PubMed
266.
Düker I, Starz H, Bachter D, Balda BR: Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology. 2001, 202: 225-229.PubMed
267.
Blom A, Kolb F, Lumbroso J, Duvillard P, Mamelle G, Morzli K, Ricard M, Spatz A, Petrow P, Margulis A, Avril MF: [Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases]. Ann Dermatol Venereol. 2003, 130: 417-422. [French]PubMed
268.
Wagner JD, Evdokimow DZ, Weisberger E, Moore D, Chuang TY, Wenck S, Coleman JJ: Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004, 140: 75-79.PubMed
269.
Michl C, Starz H, Bachter D, Balda BR: Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol. 2003, 149: 763-769.PubMed
270.
Alex JC: The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope. 2004, 114: 2-19.PubMed
271.
Schmalbach CE, Lowe L, Teknos TN, Johnson TM, Bradford CR: Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg. 2005, 131: 610-614.PubMed
272.
Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krössin T, Zander A, Audring H, Sterry W, Munz DL: Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006, 33: 433-440.PubMed
273.
Ortin-Perez J, van Rijk MC, Valdes-Olmos RA, Vidal-Sicart S, Nieweg OE, Vilalta A, Kroon BB, Pons F: Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol. 2007, 33: 119-122.PubMed
274.
Migliano E, Monarca C, Tedesco M, Rizzo MI, Bucher S: [Merkel cell carcinoma and sentinel lymph node dissection: nine cases report]. G Chir. 2008, 29: 28-32. [Italian]PubMed
275.
Argenzio V, Rambaldi PF, Iorio G, Cuccurullo V, Cascini GL, Argenziano G, Mansi L: Radioimmunoguided surgery in squamous cell carcinoma. Plast Reconstr Surg. 1999, 103: 749-751.PubMed
276.
Nouri K, Rivas MP, Pedroso F, Bhatia R, Civantos F: Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol. 2004, 140: 1284-PubMed
277.
Civantos FJ, Moffat FL, Goodwin WJ: Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006, 112 (3 Pt 2 Suppl 109): 1-15.PubMed
278.
Frerich B, Förster M, Schiefke F, Wittekind C, Hemprich A, Sabri O: Sentinel lymph node biopsy in squamous cell carcinomas of the lips and the oral cavity – a single center experience. J Surg Oncol. 2007, 95: 97-105.PubMed
279.
Stadelmann WK, Javaheri S, Cruse CW, Reintgen DS: The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg [Am]. 1997, 22: 726-731.
280.
Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA: Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003, 29: 135-140.PubMed
281.
Ozçelik D, Tatlidede S, Hacikerim S, Uğurlu K, Atay M: The use of sentinel lymph node biopsy in squamous cell carcinoma of the foot: a case report. J Foot Ankle Surg. 2004, 43: 60-63.PubMed
282.
Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, Perez-Bernal AM, Camacho F: Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol. 2005, 141: 110-111.PubMed
283.
Cuccia G, Colonna MR, Papalia I, Manasseri B, Romeo M, d'Alcontres FS: The use of sentinel node biopsy and selective lymphadenectomy in squamous cell carcinoma of the upper limb. Usefulness of sentinel node biopsy to avoid useless lymphadenectomies in high-risk upper limb SCC. Ann Ital Chir. 2008, 79: 67-71.PubMed
284.
Harwood M, Wu H, Tanabe K, Bercovitch L: Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J Am Acad Dermatol. 2005, 53: 475-478.PubMed
285.
Cózar MP, Ferrer-Rebolleda J, Redal MC, Moreno A, Tortajada L, Casáns I, Romero C: [Sentinel lymph node biopsy in cutaneous non-melanoma malignancies]. Rev Esp Med Nucl. 2006, 25: 10-14. [Spanish]PubMed
286.
Delgado R, Kraus D, Coit DG, Busam KJ: Sentinel lymph node analysis in patients with sweat gland carcinoma. Cancer. 2003, 97: 2279-2284.PubMed
287.
Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, Su LD: Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer. 2003, 97: 2285-2289.PubMed
288.
Wasserman DI, Sack J, Gonzalez-Serva A, Konnikov N, Bohac G, Demierre MF: Sentinel lymph node biopsy for a squamoid eccrine carcinoma with lymphatic invasion. Dermatol Surg. 2007, 33: 1126-1129.PubMed
289.
Aitken DR, Thurston MO, Hinkle GH, Martin DT, Haagensen DE, Houchens D, Tuttle SE, Martin EW: Portable gamma probe for radioimmune localization of experimental colon tumor xenografts. J Surg Res. 1984, 36: 480-489.PubMed
290.
Aitken DR, Hinkle GH, Thurston MO, Tuttle SE, Martin DT, Olsen J, Haagensen DE, Houchens D, Martin EW: A gamma-detecting probe for radioimmune detection of CEA-producing tumors. Successful experimental use and clinical case report. Dis Colon Rectum. 1984, 27: 279-282.PubMed
291.
Martin DT, Hinkle GH, Tuttle S, Olsen J, Nabi H, Houchens D, Thurston M, Martin EW: Intraoperative radioimmunodetection of colorectal tumors with a hand-held radiation detector. Am J Surg. 1985, 150: 672-675.PubMed
292.
Martin EW, Hinkle G, Mojzisik C, Thurston MO: Radioimmunoguided surgery: a new intraoperative approach to the detection of tumor. Cancer Treat Res. 1990, 51: 387-411.PubMed
293.
Hinkle G, Houchens D, Miller E, Nines R, Nabi H, Thurston M, Tuttle S, Mojzisik C, Martin EW: Preferential localization of antibody combinations in tumor xenografts in nude mice. Immune-Deficient Animals in Biomedical Research. Edited by: Rygaard, Brûnner, Graem, Spang-Thomsen. 1987, Workshop on Immune-Deficient Animals, Cophenhagen, 248-250. 5
294.
O'Dwyer PJ, Mojzisik CM, Hinkle GH, Tuttle SE, Rousseau M, Olsen J, Tuttle SE, Barth RF, Houchens , Thurston MO, McCabe DP, Farrar WB, Martin EW: Intraoperative probe-directed immunodetection using a monoclonal antibody. Arch Surg. 1986, 121: 1391-1394.PubMed
295.
Petty LR, Mojzisik CM, Hinkle GH, Ignaszewski J, Loesch J, Berens A, Thurston MO, Martin EW: Radioimmunoguided surgery: a phase I/II study using iodine-125 labeled to 17-1A IgG2A in patients with colorectal cancer. Antibody Immunoconjugates, Radiopharm. 1991, 4: 603-611.
296.
Colcher D, Keenan AM, Larson SM, Schlom J: Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res. 1984, 44: 5744-5749.PubMed
297.
Sardi A, Siddiqi MA, Hinkle GH, Rousseau M, Gersman M, Hill T, Olsen J, Tuttle SE, Young D, Houchens D, Thurston M, Martin EW: Localization by hand-held gamma probe of tumor labeled with antibody "cocktail". J Surg Res. 1989, 47: 227-234.PubMed
298.
Martin EW, Mojzisik CM, Hinkle GH, Sampsel J, Siddiqi M, Tuttle SE, Sickle-Santanello B, Colcher D, Thurston MO, Bell J, Farrar WB, Schlom J: Radioimmunoguided surgery using monoclonal antibody. Am J Surg. 1988, 156: 386-392.PubMed
299.
Sickle-Santanello BJ, O'Dwyer PJ, Mojzisik C, Tuttle SE, Hinkle GH, Rousseau M, Schlom J, Colcher D, Thurston MO, Nieroda C, Sardi A, Farrar WB, Minton JP, Martin EW: Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors. Dis Colon Rectum. 1987, 30: 761-764.PubMed
300.
Nieroda CA, Mojzisik C, Sardi A, Ferrara P, Hinkle G, Thurston MO, Martin EW: Radioimmunoguided surgery in primary colon cancer. Cancer Detect Prev. 1990, 14: 651-656.PubMed
301.
302.
Cohen AM, Martin EW, Lavery I, Daly J, Sardi A, Aitken D, Bland K, Mojzisik C, Hinkle G: Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch Surg. 1991, 126: 349-352.PubMed
303.
Bertoglio S, Benevento A, Percivale P, Cafiero F, Moresco L, Peressini A, Dionigi R, Badellino F: Radioimmunoguided surgery benefits in carcinoembryonic antigen-directed second-look surgery in the asymptomatic patient after curative resection of colorectal cancer. Semin Surg Oncol. 1998, 15: 263-267.PubMed
304.
Percivale P, Bertoglio S, Meszaros P, Schenone F, Gipponi M, Moresco L, Cosso M, Badellino F: Radioimmunoguided surgery with different iodine-125 radiolabeled monoclonal antibodies in recurrent colorectal cancer. Semin Surg Oncol. 1998, 15: 231-234.PubMed
305.
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W: Radioimmunoguided surgery in colorectal cancer: a 6-year experience with four different technical solutions. Semin Surg Oncol. 1998, 15: 226-230.PubMed
306.
Muxi A, Pons F, Vidal-Sicart S, Setoain FJ, Herranz R, Novell F, Fernandez RM, Trias M, Setoain J: Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody. Nucl Med Commun. 1999, 20: 123-130.PubMed
307.
Collier BD, Abdel-Nabi H, Doerr RJ, Harwood SJ, Olsen J, Kaplan EH, Winzelberg GG, Grossman SJ, Krag DN, Mitchell EP: Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. Radiology. 1992, 185: 179-186.PubMed
308.
Quinlan D, Davidson A, Gamponia E, Lindley J, Doshi H: Detection of tumor-associated glycoprotein-72 (TAG-72) in short-term and long-term surviving colon cancer patients using a first- and second-generation monoclonal antibody. Proc Am Assoc Cancer Res. 1991, 32: 271-
309.
Arnold MW, Young DC, Hitchcock CL, Schneebaum S, Martin EW: Radioimmunoguided surgery in primary colorectal carcinoma: an intraoperative prognostic tool and adjuvant to traditional staging. Am J Surg. 1995, 170: 315-318.PubMed
310.
Bertsch DJ, Burak WE, Young DC, Arnold MW, Martin EW: Radioimmunoguided surgery improves survival for patients recurrent colorectal cancer. Surg. 1995, 118: 634-638.
311.
Arnold MW, Young DC, Hitchcock CL, Barberá-Guillem E, Nieroda C, Martin EW: Staging of colorectal cancer: biology vs. morphology. Dis Colon Rectum. 1998, 41: 1-6.
312.
Avital S, Haddad R, Troitsa A, Kashtan H, Brazovsky E, Gitstein G, Skornick Y, Schneebaum S: Radioimmunoguided surgery for recurrent colorectal cancer manifested by isolated CEA elevation. Cancer. 2000, 89: 1692-1698.PubMed
313.
Haddad R, Avital S, Troitsa A, Chen J, Baratz M, Brazovsky E, Gitstein G, Kashtan H, Skornick Y, Schneebaum S: Benefits of radioimmunoguided surgery for pelvic recurrence. Eur J Surg Oncol. 2001, 27: 298-301.PubMed
314.
Schneebaum S, Troitsa A, Haddad R, Avital S, Kashtan H, Baratz M, Brazovsky E, Papo J, Skornick Y: Immunoguided lymph node dissection in colorectal cancer: a new challenge?. World J Surg. 2001, 25: 1495-1498. discussion 1499PubMed
315.
Agnese DM, Abdessalam SF, Burak WE, Arnold MW, Soble D, Hinkle GH, Young D, Kazaeli MB, Martin EW: Pilot study using a humanized CC49 monoclonal antibody (HuCC49ΔCH 2) to localize recurrent colorectal carcinoma. J Surg Onc. 2004, 11: 197-202.
316.
Lechner P, Lind P, Snyder M, Haushofer H: Probe-guided surgery for colorectal cancer. Recent Results Cancer Res. 2000, 157: 273-280.PubMed
317.
Nastro P, Sodo M, Dodaro CA, Gargiulo S, Acampa W, Bracale U, Renda A: Intraoperative radiochromoguided mapping of sentinel lymph node in colon cancer. Tumori. 2002, 88: 352-353.PubMed
318.
Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ: Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg. 2003, 7: 340-345. discussion 345–346PubMed
319.
Bilchik AJ, Nora DT, Sobin LH, Turner RR, Trocha S, Krasne D, Morton DL: Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol. 2003, 21: 668-672.PubMed
320.
Patten LC, Berger DH, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary KR, Fagan SP, Curley SA, Hunt KK, Feig BW: A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004, 100: 2104-2109.PubMed
321.
Saha S, Dan AG, Berman B, Wiese D, Schochet E, Barber K, Choudhri S, Kaushal S, Ganatra B, Desai D, Nagaraju M, Mannam S: Lymphazurin 1% versus 99mTc sulfur colloid for lymphatic mapping in colorectal tumors: a comparative analysis. Ann Surg Oncol. 2004, 11: 21-26.PubMed
322.
Bembenek A, Rau B, Moesta T, Markwardt J, Ulmer C, Gretschel S, Schneider U, Slisow W, Schlag PM: Sentinel lymph node biopsy in rectal cancer – not yet ready for routine clinical use. Surgery. 2004, 135: 498-505. discussion 506–507PubMed
323.
Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJ: Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2007, 15: 46-51.PubMed
324.
Bembenek A, Gretschel S, Schlag PM: Sentinel lymph node biopsy for gastrointestinal cancers. J Surg Oncol. 2007, 96: 342-352.PubMed
325.
Keshtgar MR, Amin A, Taylor I, Ell PJ: The sentinel node in anal carcinoma. Eur J Surg Oncol. 2001, 27: 113-114.PubMed
326.
Rabbitt P, Pathma-Nathan N, Collinson T, Hewett P, Rieger N: Sentinel lymph node biopsy for squamous cell carcinoma of the anal canal. ANZ J Surg. 2002, 72: 651-654.PubMed
327.
Mistrangelo M, Mobiglia A, Mussa B, Bellò M, Pelosi E, Goss M, Bosso MC, Moro F, Sandrucci S: The sentinel node in anal carcinoma. Tumori. 2002, 88: S51-S52.PubMed
328.
Péley G, Farkas E, Sinkovics I, Kovács T, Keresztes S, Orosz Z, Köves I: Inguinal sentinel lymph node biopsy for staging anal cancer. Scand J Surg. 2002, 91: 336-338.PubMed
329.
Perera D, Pathma-Nathan N, Rabbitt P, Hewett P, Rieger N: Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum. 2003, 46: 1027-1029. discussion 1030–1031PubMed
330.
Ulmer C, Bembenek A, Gretschel S, Markwardt J, Koswig S, Slisow W, Schneider U, Schlag PM: Sentinel node biopsy in anal cancer – a promising strategy to individualize therapy. Onkologie. 2003, 26: 456-460.PubMed
331.
Bobin JY, Gérard JP, Chapet O, Romestaing P, Isaac S: [Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation]. Cancer Radiother. 2003, 7 (Suppl 1): 85s-90s. [French]PubMed
332.
Damin DC, Rosito MA, Gus P, Spiro BL, Amaral BB, Meurer L, Cartel A, Schwartsmann G: Sentinel lymph node procedure in patients with epidermoid carcinoma of the anal canal: early experience. Dis Colon Rectum. 2003, 46: 1032-1037.PubMed
333.
Ulmer C, Bembenek A, Gretschel S, Markwardt J, Koswig S, Schneider U, Schlag PM: Refined staging by sentinel lymph node biopsy to individualize therapy in anal cancer. Ann Surg Oncol. 2004, 11 (3 Suppl): 259S-262S.PubMed
334.
Mistrangelo M, Mobiglia A, Bellò M, Beltramo G, Cassoni P, Mussa A: [The technique of sentinel lymph nodes in patients with anus neoplasm]. Suppl Tumori. 2005, 4: S32-S33. [Italian]PubMed
335.
Damin DC, Rosito MA, Schwartsmann G: Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol. 2006, 32: 247-252.PubMed
336.
Gretschel S, Warnick P, Bembenek A, Dresel S, Koswig S, String A, Hünerbein M, Schlag PM: Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canal. Eur J Surg Oncol. 2008, 34: 890-894.PubMed
337.
Mistrangelo M, Bellò M, Mobiglia A, Beltramo G, Cassoni P, Milanesi E, Cornaglia S, Pelosi E, Giunta F, Sandrucci S, Mussa A: Feasibility of the sentinel node biopsy in anal cancer. Q J Nucl Med Mol Imaging. 2008,
338.
Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Matsuda J, Kumai K, Ikeda T, Kubo A, Kitajima M: Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol. 2001, 8 (9 Suppl): 86S-89S.PubMed
339.
Kitagawa Y, Kitajima M: Gastrointestinal cancer and sentinel node navigation surgery. J Surg Oncol. 2002, 79: 188-193.PubMed
340.
Tajima T, Tokuda Y, Yasuda S: [The sentinel navigation surgery: current review and future perspective]. Nippon Rinsho. 2002, 60: 197-205.PubMed
341.
Kitagawa Y, Fujii H, Mukai M, Kubo A, Kitajima M: Current status and future prospects of sentinel node navigational surgery for gastrointestinal cancers. Ann Surg Oncol. 2004, 11: 242S-244S.PubMed
342.
Kitagawa Y, Kitajima M: Lymphatic mapping for upper gastrointestinal malignancies. Semin Oncol. 2004, 31: 409-414.PubMed
343.
Takeuchi H, Kitagawa Y: Sentinel node navigation surgery for esophageal cancer. Gen Thorac Cardiovasc Surg. 2008, 56: 393-396.PubMed
344.
Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Ohgami M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Kumai K, Ikeda T, Nakahara T, Kubo A, Kitajima M: The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am. 2000, 80: 1799-1809.PubMed
345.
Yasuda S, Shimada H, Ogoshi K, Tanaka H, Kise Y, Kenmochi T, Soeda J, Nakamura K, Kato Y, Kijima H, Suzuki Y, Fujii H, Tajima T, Makuuchi H: Preliminary study for sentinel lymph node identification with Tc-99m tin colloid in patients with esophageal or gastric cancer. Tokai J Exp Clin Med. 2001, 26: 15-18.PubMed
346.
Yasuda S, Shimada H, Chino O, Tanaka H, Kenmochi T, Takechi M, Nabeshima K, Okamoto Y, Kato Y, Kijima H, Suzuki Y, Ogoshi K, Tajima T, Makuuchi H: Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol. 2003, 33: 68-72.PubMed
347.
Kato H, Miyazaki T, Nakajima M, Takita J, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H, Oriuchi N, Endo K: Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer. 2003, 98: 932-939.PubMed
348.
Yasuda S, Shimada H, Chino O, Nishi T, Takechi M, Makuuchi H: [Sentinel lymph node concept in patients with esophageal cancer]. Gan To Kagaku Ryoho. 2005, 32: 877-881. [Japanese]PubMed
349.
Arima H, Natsugoe S, Uenosono Y, Arigami T, Ehi K, Yanagita S, Higashi H, Ishigami S, Hokita S, Aikou T: Area of nodal metastasis and radioisotope uptake in sentinel nodes of upper gastrointestinal cancer. J Surg Res. 2006, 135: 250-254.PubMed
350.
Kosugi S, Nakagawa S, Kanda T, Odano I, Yajima K, Kaneko K, Ohashi M, Hatakeyama K: Radio-guided sentinel node mapping in patients with superficial esophageal carcinoma: feasibility study. Minim Invasive Ther Allied Technol. 2007, 16: 181-186.PubMed
351.
Lamb PJ, Griffin SM, Burt AD, Lloyd J, Karat D, Hayes N: Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005, 92: 60-67.PubMed
352.
Burian M, Stein HJ, Sendler A, Piert M, Nährig J, Feith M, Siewert JR: Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol. 2004, 11 (3 suppl): 255S-258S.PubMed
353.
Bonenkamp JJ, Hermans J, Sasako M, Velde van de CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999, 340: 908-914.PubMed
354.
Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999, 79: 1522-1530.PubMedCentralPubMed
355.
Fass J, Hungs M, Reineke T, Nachtkamp J, Schumpelick V: Prognostic improvement by R1 and R2 lymphadenectomy in stomach carcinoma. Chirurg. 1994, 65: 867-872.PubMed
356.
Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993, 80: 1015-1018.PubMed
357.
Sasako M, McCulloch P, Kinoshita T, Maruyama K: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995, 82: 346-351.PubMed
358.
Aikou T, Higashi H, Natsugoe S, Hokita S, Baba M, Tako S: Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer?. Ann Surg Oncol. 2001, 8 (9 Suppl): 90S-93S.PubMed
359.
Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M: Radio-guided sentinel node detection for gastric cancer. Br J Surg. 2002, 89: 604-608.PubMed
360.
Hayashi H, Ochiai T, Mori M, Karube T, Suzuki T, Gunji Y, Hori S, Akutsu N, Matsubara H, Shimada H: Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg. 2003, 196: 68-74.PubMed
361.
Tonouchi H, Mohri Y, Tanaka K, Konishi N, Ohmori Y, Kobayashi M, Watanabe Y, Matsumura K, Takeda K, Kusunoki M: Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig Surg. 2003, 20: 421-427.PubMed
362.
Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM: [Lymphatic mapping and sentinel lymph node biopsy in gastric cancer]. Chirurg. 2003, 74: 132-138. [German]PubMed
363.
Asao T, Kuwano H, Ide M, Hirayama I, Nakamura J, Endo K: Intraoperative location of small gastrointestinal cancers with a handheld gamma probe. Surg Endosc. 2003, 17: 1216-1217.PubMed
364.
Uenosono Y, Natsugoe S, Higashi H, Ehi K, Miyazono F, Ishigami S, Hokita S, Aikou T: Evaluation of colloid size for sentinel nodes detection using radioisotope in early gastric cancer. Cancer Lett. 2003, 200: 19-24.PubMed
365.
Kim MC, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS: Sentinel lymph node biopsy with 99mTC tin-colloid in patients with gastric carcinoma. Hepatogastroenterology. 2003, 50 (Suppl 2): 214-215.
366.
Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS: Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg. 2004, 239: 383-387.PubMedCentralPubMed
367.
Tanaka K, Tonouchi H, Kobayashi M, Konishi N, Ohmori Y, Mohri Y, Kusunoki M: Laparoscopically assisted total gastrectomy with sentinel node biopsy for early gastric cancer: preliminary results. Am Surg. 2004, 70: 976-981.PubMed
368.
Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM: Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol. 2005, 31: 393-400.PubMed
369.
Uenosono Y, Natsugoe S, Ehi K, Arigami T, Hokita S, Aikou T: Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg. 2005, 92: 886-889.PubMed
370.
Cheng LY, Chen XD, Zhang YX, Feng XD: [Clinical significance of sentinel lymph node detection by combining the dye-directed and radioguided methods in gastric cancer]. Zhonghua Wai Ke Za Zhi. 2005, 43: 569-572. [Chinese]PubMed
371.
Tonouchi H, Mohri Y, Tanaka K, Kobayashi M, Ohmori Y, Kusunoki M: Laparoscopic lymphatic mapping and sentinel node biopsies for early-stage gastric cancer: the cause of false negativity. World J Surg. 2005, 29: 418-421.PubMed
372.
Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G: Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005, 138: 899-904.PubMed
373.
Mura G, Vagliasindi A, Framarini M, Mazza P, Solfrini G, Verdecchia GM: The sentinel node biopsy in early gastric cancer: a preliminary study. Langenbecks Arch Surg. 2006, 391: 113-117.PubMed
374.
Mochiki E, Kuwano H, Kamiyama Y, Aihara R, Nakabayashi T, Katoh H, Asao T, Oriuchi N, Endo K: Sentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinoma. Am J Surg. 2006, 191: 465-469.PubMed
375.
Ichikura T, Chochi K, Sugasawa H, Yaguchi Y, Sakamoto N, Takahata R, Kosuda S, Mochizuki H: Individualized surgery for early gastric cancer guided by sentinel node biopsy. Surgery. 2006, 139: 501-507.PubMed
376.
Lee JH, Ryu KW, Kim CG, Kim SK, Lee JS, Kook MC, Choi IJ, Kim YW, Chang HJ, Bae JM: Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol. 2006, 13: 1168-1174.PubMed
377.
Saikawa Y, Otani Y, Kitagawa Y, Yoshida M, Wada N, Kubota T, Kumai K, Sugino Y, Mukai M, Kameyama K, Kubo A, Kitajima M: Interim results of sentinel node biopsy during laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World J Surg. 2006, 30: 1962-1968.PubMed
378.
Tonouchi H, Mohri Y, Kobayashi M, Tanaka K, Ohi M, Kusunoki M: Laparoscopy-assisted distal gastrectomy with laparoscopic sentinel lymph node biopsy after endoscopic mucosal resection for early gastric cancer. Surg Endosc. 2007, 21: 1289-1293.PubMed
379.
Gretschel S, Bembenek A, Hünerbein M, Dresel S, Schneider W, Schlag PM: Efficacy of different technical procedures for sentinel lymph node biopsy in gastric cancer staging. Ann Surg Oncol. 2007, 14: 2028-2035.PubMed
380.
Ishigami S, Natsugoe S, Uenosono Y, Yanagita S, Matsumoto M, Okumura H, Uchikado Y, Arigami T, Arima H, Setoyama T, Aikou T: Usefulness of sentinel node biopsy in laparoscopic partial gastrectomy for early gastric cancer. Hepatogastroenterology. 2007, 54: 2164-2166.PubMed
381.
Lee JH, Ryu KW, Kook MC, Lee JY, Kim CG, Choi IJ, Kim SK, Jang S, Park SR, Kim YW, Nam BH, Bae JM: Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol. 2008, 98: 331-335.PubMed
382.
Lee YJ, Ha WS, Park ST, Choi SK, Hong SC, Park JW: Which biopsy method is more suitable between a basin dissection and pick-up biopsy for sentinel nodes in laparoscopic sentinel-node navigation surgery (LSNNS) for gastric cancer?. J Laparoendosc Adv Surg Tech A. 2008, 18: 357-363.PubMed
383.
Xu G, Zhang M, Liu B, Li Z, Lin B, Xu X, Jin M, Li J, Wu J, Dong Z: Radioimmunoguided surgery in gastric cancer using 131-I labeled monoclonal antibody 3H11. Semin Surg Oncol. 1994, 10: 88-94.PubMed
384.
Liu BG, Xu GW, Zhang MY: [A clinical trial of radioimmunoguided surgery for gastric cancer]. Zhonghua Zhong Liu Za Zhi. 1994, 16: 284-287. [Chinese]PubMed
385.
Lucisano E, Bertoglio S: Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery. Semin Surg Oncol. 1998, 15: 212-214.PubMed
386.
Mussa A, Sandrucci S, Mobiglia A, Baccega M, Mussa B, De Filippi PG: Role of radioimmunolocalization in the staging of gastric carcinoma. Semin Surg Oncol. 1998, 15: 209-211.PubMed
387.
Wang C, Wang Y, Su X, Lin B, Xu X, Zhang M, Li J, Xu G: [Iodine-125 labeled monoclonal antibody 3H11: in radioimmunoguided surgery for primary gastric cancer]. Zhonghua Wai Ke Za Zhi. 2000, 38: 507-509. [Chinese]PubMed
388.
LaValle GJ, Martinez DA, Sobel D, DeYoung B, Martin EW: Assessment of disseminated pancreatic cancer: a comparison of traditional exploratory laparotomy and radioimmunoguided surgery. Surgery. 1997, 122: 867-871. discussion 871–873PubMed
389.
Dunne AA, Budach VG, Wagner W, Werner J: Management of NO neck in head and neck cancer: current controversies. Onkologie. 2004, 27: 363-367.PubMed
390.
Alex JC, Krag DN: Gamma-probe guided resection of radio-labeled primary lymph nodes. Surg Oncol Clin N Am. 1996, 5: 33-41.PubMed
391.
Chikamatsu K, Kamada H, Ninomiya H, Takahashi K, Sakurai T, Oriuchi N, Furuya N: A preliminary study on sentinel lymph node biopsy: feasibility and predictive ability in oral cavity cancer. Ann Nucl Med. 2004, 18: 257-262.PubMed
392.
Civantos F, Zitsch R, Bared A: Sentinel Node Biopsy in Oral Squamous Cell Carcinoma. Journal of Surgical Oncology. 2007, 96: 330-336.PubMed
393.
Stoeckli SJ: Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope. 2007, 117: 1539-1551.PubMed
394.
Werner JA, Dünne AA, Ramaswamy A, Brandt D, Külkens C, Folz BJ, Moll R, Lippert BM: [The sentinel node concept in head and neck squamous cell carcinoma – a critical analysis in 100 patients]. Laryngorhinootologie. 2002, 81: 31-39. [German]PubMed
395.
Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri I, Roberton AG, Sorensen JA, Thomsen J, Grupe P, Alvarez J, Barbier L, Santamaria J, Poli T, Massarelli O, Sesenna E, Kovacs AF, Grunwald F, Barzan L, Sulfaro S, Alberti F: Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol. 2004, 11: 690-696.PubMed
396.
Vigili MG, Tartaglione G, Rahimi S, Mafera B, Pagan M: Lymphoscintigraphy and radioguided sentinel node biopsy in oral cavity sqaumous cell carcinoma: same day protocol. Eur Arch Otorhinolaryngol. 2007, 264: 163-167.PubMed
397.
Tomifuji M, Shiotani A, Fujii H, Araki K, Saito K, Inagaki K, Mukai M, Kitagawa Y, Ogawa K: Sentinel node concept in clinically n0 laryngeal and hypopharyngeal cancer. Ann Surg Oncol. 2008, 15: 2568-2575.PubMed
398.
Atula T, Shoaib T, Ross GL, Gray HW, Soutar DS: How many sentinel nodes should be harvested in oral squamous cell carcinoma?. Eur Arch Otorhinolaryngol. 2007, 265 (Suppl 1): S19-S23.PubMed
399.
Jesse RH, Ballantyne AJ, Larson D: Radical or modified radical neck dissection: a therapeutic dilemma. Am J Surg. 1978, 136: 516-519.PubMed
400.
401.
Kovács AF, Landes CA, Hamscho N, Risse JH, Berner U, Menzel C: Sentinel node biopsy as staging tool in a multi-modality treatment approach to cancer of the oral cavity and oropharynx. Otolaryngol Head Neck Sug. 2005, 132: 570-576.
402.
Matsuzuka T, Kano M, Ohtani I, Miura T, Shishido F, Omori K: Impact of sentinel node navigation technique for carcinoma of the tongue with cervical node metastases. Auris Nasus Larynx. 2005, 32: 59-63.PubMed
403.
Mozzillo N, Chiesa F, Caraco C, Botti G, Lastoria S, Longo F, Ionna F: Therapeutic implications of sentinel lymph node bipsy in the staging of oral cancer. Ann Surg Oncol. 2004, 11 (3 Suppl): 263S-266S.PubMed
404.
Kovács AF: Head and neck squamous cell carcinoma: sentinel node or selective neck dissection. Surg Oncol Clin N Am. 2007, 16: 81-100.PubMed
405.
Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P: Frequency and therapeutic implications of skip metastases in neck from squamous carcinoma of the oral tongue. Head Neck. 1997, 19: 14-19.PubMed
406.
Argenzio V, Rambaldi PF, Iorio G, Cuccurullo V, Cascini G, Argenzio G, Mansi L: Radioimmunoguided surgery in squamous cell carcinoma. J Am Soc Plas Surg. 1999, 103: 749-751.
407.
Kaplan E, Yashiro T, Salti G: Primary hyperaparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 1992, 215: 300-317.PubMedCentralPubMed
408.
Ubhi CS, Hardy JG, Pegg CA: Mediastinal parathyroid adenoma: a new method of localization. Br J Surg. 1984, 71: 859-860.PubMed
409.
Martinez DA, King DR, Romshe C, Lozano RA, Morris JD, O'Dorisio MS, Martin E: Intraoperative identification of parathyroid gland pathology: a new approach. J Pediatr Surg. 1995, 30: 1306-1309.PubMed
410.
Norman J, Chheda : Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997, 122: 998-1003. discussion 1003–1004PubMed
411.
Murphy C, Norman J: The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999, 126: 1023-1028. discussion 1028–1029PubMed
412.
Flynn MB, Bumpous JM, Schill K, McMasters KM: Minimally invasive radioguided parathyroidectomy. J Am Coll Surg. 2000, 191: 24-31.PubMed
413.
Goldstein RE, Blevins L, Delbeke D, Martin WH: Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg. 2000, 231: 732-742.PubMedCentralPubMed
414.
Norman J, Jaffray CE, Chheda H: The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy. Ann Surg. 2000, 231: 31-37.PubMedCentralPubMed
415.
Dackiw AP, Sussman JJ, Fritsche HA, Delpassand ES, Stanford P, Hoff A, Gagel RF, Evans DB, Lee JE: Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg. 2000, 135: 550-555. discussion 555–557PubMed
416.
Casara D, Rubello D, Pelizzo MR, Shapiro B: Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med. 2001, 28: 1351-1359.
417.
McGreal G, Winter DC, Sookhai S, Evoy D, Ryan M, O'Sullivan GC, Redmond HP: Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol. 2001, 8: 856-860.PubMed
418.
Rubello D, Casara D, Saladini G, Piotto A, Pagetta C, Pelizzo MR: 99mTc-MIBI radio-guided surgery in primary hyperparathyroidism: a prospective study of 128 patients. Tumori. 2002, 88: S63-S65.PubMed
419.
Rubello D, Piotto , Casara D, Muzzio PC, Shapiro B, Pelizzo MR: Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures. Eur J Endocrinol. 2003, 149: 7-15.PubMed
420.
Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, Pelizzo MR: Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q J Nucl Med. 2003, 47: 129-138.PubMed
421.
Rubello D, Pelizzo MR, Boni G, Schiavo R, Vaggelli L, Villa G, Sandrucci S, Piotto A, Manca G, Marini P, Mariani G: Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multiinstitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). J Nucl Med. 2005, 46: 220-226.PubMed
422.
Rubello D, Giannini S, Martini C, Piotto A, Rampin L, Fanti S, Armigliato M, Nardi A, Carpi A, Mariani G, Gross MD, Pelizzo MR: Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother. 2006, 60: 134-138.PubMed
423.
Rubello D, Mariani G, Al-Nahhas A, Pelizzo MR, Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS): Minimally invasive radio-guided parathyroidectomy: long-term results with the "low 99mTc-sestamibi protocol". Nucl Med Commun. 2006, 27: 709-713.PubMed
424.
Rubello D, Mariani G, Pelizzo MR, Italian Study Group of Radioguided Surgery and ImmunoScintigraphy: Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients: refinement of preoperative imaging and intraoperative procedure. Nuklearmedizin. 2007, 46: 85-92.PubMed
425.
Shabtai M, Ben-Haim M, Muntz Y, Vered I, Rosin D, Kuriansky J, Zmora O, Olchovski D, Ayalon A, Zwas ST: 140 consecutive cases of minimally invasive, radio-guided parathyroidectomy: lessons learned and long-term results. Surg Endosc. 2003, 17: 688-691.PubMed
426.
Bekiş R, Aydin A, Taşci C, Atila K, Koçdor MA, Sevinç A, Canda S, Harmancioğlu O, Durak H: The role of gamma probe activity counts in minimally invasive parathyroidectomy. Preliminary results. Nuklearmedizin. 2004, 43: 190-194.PubMed
427.
Goldstein RE, Billheimer D, Martin WH, Richards K: Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg. 2003, 237: 722-730. discussion 730–731PubMedCentralPubMed
428.
Chen H, Pruhs Z, Starling JR, Mack E: Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005, 138: 583-587. discussion 587–590PubMed
429.
Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW: Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg. 2006, 72: 785-789. discussion 790PubMed
430.
Norman J, Politz D: Measuring individual parathyroid gland hormone production in real-time during radioguided parathyroidectomy. Experience in over 8000 operations. Minerva Endocrinol. 2008, 33: 147-157.PubMed
431.
Lal A, Chen H: The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?. Ann Surg Oncol. 2007, 14: 2363-2366.PubMed
432.
Rossi HL, Ali A, Prinz RA: Intraoperative sestamibi scanning in reoperative parathyroidectomy. Surgery. 2000, 128: 744-750.PubMed
433.
Navarra G, Ascanelli S, Feggi L, Carcoforo P, Turini A: Radio-guided surgery in recurrent renal hyperparathyroidism: report of a case. Head Neck. 2000, 22: 618-620.PubMed
434.
Navarra G, Feggi L, Ascanelli S, Turini A, Carcoforo P, De Paoli E, Pozza E: Role of radio-guided surgery in recurrent secondary hyperparathyroidism. Nephron. 2001, 88: 36-38.PubMed
435.
Geissler B, Gröber S, Zügel N, Lindemann F: [Radio-guided parathyroidectomy: successful intraoperative parathyroid localization diagnosis with 99mTc-sestamibi in primary and recurrent hyperparathyroidism]. Chirurg. 2001, 72: 1179-1185. [German]PubMed
436.
Chen H, Mack E, Starling JR: Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg. 2003, 238: 332-337. discussion 337–338PubMedCentralPubMed
437.
Nichol PF, Mack E, Bianco J, Hayman A, Starling JR, Chen H: Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery. 2003, 134: 713-717. discussion 717–719PubMed
438.
Kitagawa W, Shimizu K, Akasu H, Tanaka S: Radioguided parathyroidectomy for renal hyperparathyroidism. Med Sci Monit. 2003, 9: CS9-CS12.PubMed
439.
Ogi S, Fukumitsu N, Uchiyama M, Mori Y, Takeyama H: The usefulness of radio-guided surgery in secondary hyperparathyroidism. Ann Nucl Med. 2004, 18: 69-71.PubMed
440.
Takeyama H, Shioya H, Mori Y, Ogi S, Yamamoto H, Kato N, Kinoshita S, Yoshida K, Uchida K, Yamazaki Y: Usefulness of radio-guided surgery using technetium-99m methoxyisobutylisonitrile for primary and secondary hyperparathyroidism. World J Surg. 2004, 28: 576-582.PubMed
441.
Kebebew E, Arici C, Duh QY, Clark OH: Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001, 136: 878-885.PubMed
442.
Placzkowski K, Christian R, Chen H: Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med. 2007, 32: 358-360.PubMed
443.
Carcoforo P, Feggi L, Trasforini G, Lanzara S, Sortini D, Zulian V, Pansini GC, Degli Uberti E, Liboni A: Use of preoperative lymphoscintigraphy and intraoperative gamma probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. Eur J Sug Oncol. 2007, 33: 1075-1080.
444.
Mazzaferri EL, Kloos RT: Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001, 86: 1447-1463.PubMed
445.
Salvatori M, Rufini V, Reale F, Gajate AM, Maussier ML, Revelli L, Troncone L, Ardito G: Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg. 2003, 27: 770-775.PubMed
446.
Rubello D, Salvatori M, Ardito G, Al-Nahhas A, Gross M, Muzzio P, Pelizzo M: Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother. 2007, 61: 477-81.PubMed
447.
Negele T, Meisetschläger G, Brückner T, Scheidhauer K, Schwaiger M, Vogelsang H: Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature. Langenbecks Arch Surg. 2006, 391: 178-186.PubMed
448.
Robbins R, Schlumberger M: The evolving role of 131 I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 2005, 46: 28S-37S.PubMed
449.
Vassilopoulou-Sellin R, Schultz PN, Haynie TP: Clinical outcomes of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer. 1996, 78: 273-282.
450.
Vassilopoulou-Sellin R: Long-term outcomes of children with papillary thyroid cancer. Surgery. 2001, 129: 769-PubMed
451.
Haugen BR: Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol. 1999, 16: 34-41.PubMed
452.
Morris AC, Barclay TR, Tanida R, Nemcek JV: A miniaturized probe for detecting radioactivity at thyroid surgery. Phys Med Biol. 1971, 16: 397-404.PubMed
453.
Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C: Combination of radioiodine (131 I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab. 1998, 83: 2675-2680.PubMed
454.
Scurry WC, Lamarre E, Stack B: Radioguided neck dissection in recurrent metastatic papillary thyroid carcinoma. Am J Otolaryngol. 2006, 27: 61-63.PubMed
455.
Gallowitsch H, Fellinger J, Mikosch P, Kresnik E, Lind P: Gamma-probe guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma. Clin Nucl Med. 1997, 22: 591-592.PubMed
456.
Khandelwal S, Sener S, Purdy L, Perlman R: I-123-Guided excision of metastatic papillary thyroid cancer. J Surg Onc. 2007, 96: 173-175.
457.
Shimotake T, Tsuda T, Aoi S, Fumino S, Iwai N: Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. J Pediatr Surg. 2005, 40: 1643-1646.PubMed
458.
Alam MS, Kasai K, Miisaki T, Miyamato S, Iwata M, Iida Y, Knishi J: Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation. Thyroid. 1998, 8: 1091-1100.PubMed
459.
Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C: Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med. 1996, 23: 1367-1371.PubMed
460.
Chen YK, Liu FY, Yen RF, Kao CH: Compare FDG-PET and Tc-99m tetrafosmin SPECT to detect metastatic thyroid carcinoma. Acad Radiol. 2003, 10: 835-839.PubMed
461.
Rubello D, Pelizzo MR, Casara D, Piotto A, Toniato A, Fig L, Gross M: Radio-guided surgery for non-131 I-avid thyroid cancer. Thyroid. 2006, 16: 1105-1111.PubMed
462.
Rubello D, Piotto A, Pagetta C, Pelizzo MR, Casara D: (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med Mol Imaging. 2002, 29: 1201-1205.PubMed
463.
Adams S, Acker P, Lorenz M, Staib-Sebler E, Hör G: Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings. Cancer. 2001, 92: 263-270.PubMed
464.
Stokkel M, Verkooijen , Smit J: Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value. Eur J Nucl Med Mol Imaging. 2004, 31: 950-957.PubMed
465.
Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M: Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med. 1993, 34: 1267-1273.PubMed
466.
Barbet J, Peltier P, Bardet S, Vuillez JP, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Huglo D, Proye C, Rouvier E, Meyer P, Chatal JF: Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA × anti-DTPA-indium bispecific antibody. J Nucl Med. 1998, 39: 1172-1178.PubMed
467.
de Labriolle-Vaylet C, Cattan P, Sarfati E, Wioland M, Billotey C, Brochériou C, Rouvier E, de Roquancourt A, Rostène W, Askienazy S, Barbet J, Milhaud G, Gruaz-Guyon A: Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. Clin Cancer Res. 2000, 6: 363-371.PubMed
468.
Meller B, Sahlmann C, Horstmann O, Gerl J, Baehre M, Meller J: Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG. Nuklearmedizin. 2005, 44: N23-N25.PubMed
469.
Curtet C, Carlier T, Mirallié E, Bodet-Milin C, Rousseau C, Barbet J, Kraeber-Bodéré F: Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence. Eur J Nucl Med Mol Imaging. 2007, 34: 1556-1562.PubMed
470.
Agrawal A, Hall NC, Ringel MD, Povoski SP, Martin EW: Combined use of perioperative TSH-stimulated 18F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma. Laryngoscope. 2008, 118: 2190-4.PubMed
471.
Helal BO, Merlet P, Tourbert ME, Franc B, Schwartz C, Gauthier-Koelesnikov H, Prigent A, Syrota A: Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med. 2001, 42: 1464-1469.PubMed
472.
Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack H: Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999, 26: 1547-1552.PubMed
473.
Shaha AR: Management of the neck in thyroid cancer. Otolaryngol Clin North Am. 1998, 31: 823-831.PubMed
474.
Grebe SK, Hay ID: Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996, 5: 43-63.PubMed
475.
476.
Rettenbacher L, Sungler P, Gmeiner D, Kassmann H, Galvan G: Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med. 2000, 27: 1399-1401.PubMed
477.
Catarci M, Zaraca F, Angeloni R, Mancini B, de Filippo MG, Massa R, Carboni M, Pasquini G: Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J Surg Oncol. 2001, 77: 21-24. discussion 25PubMed
478.
Wiseman S, Hicks W, Chu QD, Rigual NR: Sentinel lymph node biopsy in staging of differential thyroid cancer: a critical review. Surg Oncol. 2002, 11: 137-142.PubMed
479.
Stoeckli SJ, Pfaltz M, Steinert H, Schmid S: Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol. 2003, 260: 364-368.PubMed
480.
Rubello D, Pelizzo MR, Al-Nahhas A, Salvatori M, O'Doherty MJ, Giuliano AE, Gross MD, Fanti S, Sandrucci S, Casara D, Mariani G: The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol. 2006, 32: 917-921.PubMed
481.
Pelizzo MR, Merante Boschin I, Toniato A, Piotto A, Bernante P, Paggetta C, De Salvo GL, Carpi A, Rubello D, Casara D: Sentinel node mapping and biopsy in thyroid cancer: a surgical perspective. Biomed Pharmacother. 2006, 60: 405-408.PubMed
482.
Pelizzo MR, Rubello D, Boschin IM, Piotto A, Paggetta C, Toniato A, De Salvo GL, Giuliano A, Mariani G, Casara D: Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging. 2007, 34: 934-938.PubMed
483.
Gould EA, Winship T, Philbin PH, Kerr HH: Observations on a "sentinel node" in cancer of the parotid. Cancer. 1960, 13: 77-78.PubMed
484.
Stárek I, Koranda P, Zboøil V, Mrzena L: Sentinel lymph node biopsy in parotid gland carcinoma. Clin Nucl Med. 2006, 31: 203-204.PubMed
485.
Decesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS, Puleo C, Cavanagh D: A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol. 1997, 66: 425-428.PubMed
486.
de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, Boonstra H, Zee van der AG: Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med. 1998, 39: 1381-1385.PubMed
487.
Terada KY, Coel MN, Ko P, Wong JH: Combined use of intraoperative lymphatic mapping and lymphoscintigraphy in the management of squamous cell cancer of the vulva. Gynecol Oncol. 1998, 70: 65-69.PubMed
488.
Bowles J, Terada KY, Coel MN, Wong JH: Preoperative lymphoscintigraphy in the evaluation of squamous cell cancer of the vulva. Clin Nucl Med. 1999, 24: 235-238.PubMed
489.
Rodier JF, Janser JC, Routiot T, David E, Ott G, Schneegans O, Ghnassia JP: Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol Rep. 1999, 6: 1249-1252.PubMed
490.
Sideri M, De Cicco C, Maggioni A, Colombo N, Bocciolone L, Trifirò G, De Nuzzo M, Mangioni C, Paganelli G: Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori. 2000, 86: 359-363.PubMed
491.
De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, Maggioni A, Bocciolone L, Mangioni C, Colombo N, Paganelli G: Sentinel node biopsy in early vulvar cancer. Br J Cancer. 2000, 82: 295-299.PubMed
492.
Molpus KL, Kelley MC, Johnson JE, Martin WH, Jones HW: Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med. 2001, 46: 863-869.PubMed
493.
Sliutz G, Reinthaller A, Lantzsch T, Mende T, Sinzinger H, Kainz C, Koelbl H: Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol. 2002, 84: 449-452.PubMed
494.
Zámbó K, Schmidt E, Hartmann T, Kornya L, Dehghani B, Tinneberg HR, Bódis J: Preliminary experiences with sentinel lymph node detection in cases of vulvar malignancy. Eur J Nucl Med Mol Imaging. 2002, 29: 1198-1200.PubMed
495.
Puig-Tintoré LM, Ordi J, Vidal-Sicart S, Lejárcegui JA, Torné A, Pahisa J, Iglesias X: Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol. 2003, 88: 29-34.PubMed
496.
Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM: Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol. 2003, 91: 378-382.PubMed
497.
Merisio C, Berretta R, Gualdi M, Pultrone DC, Anfuso S, Agnese G, Aprile C, Mereu L, Salamano S, Tateo S, Melpignano M: Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer. 2005, 15: 493-497.PubMed
498.
Wydra D, Sawicki S, Emerich J, Romanowicz G: Evaluation of sentinel node detection in vulvar cancer. Nucl Med Rev Cent East Eur. 2005, 8: 128-130.PubMed
499.
Dhar KK, Woolas RP: Lymphatic mapping and sentinel node biopsy in early vulvar cancer. BJOG. 2005, 112: 696-702.PubMed
500.
Terada KY, Shimizu DM, Jiang CS, Wong JH: Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol. 2006, 102: 200-203.PubMed
501.
Nyberg RH, Iivonen M, Parkkinen J, Kuoppala T, Mäenpää JU: Sentinel node and vulvar cancer: a series of 47 patients. Acta Obstet Gynecol Scand. 2007, 86: 615-619.PubMed
502.
Vidal-Sicart S, Puig-Tintoré LM, Lejárcegui JA, Paredes P, Ortega ML, Muñoz A, Ordi J, Fusté P, Ortín J, Duch J, Martín F, Pons F: Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging. 2007, 34: 384-391.PubMed
503.
Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Coverns A: Sentinel lymph node in vulvar cancer. Cancer. 2007, 110: 1015-1022.PubMed
504.
Rob L, Robova H, Pluta M, Strnad P, Kacirek J, Skapa P, Taborska K: Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecol Cancer. 2007, 17: 147-153.PubMed
505.
Loar PV, Reynolds RK: Sentinel lymph node mapping in gynecologic malignancies. Int J Gynaecol Obstet. 2007, 99: 69-74.PubMed
506.
Ayhan A, Celik H, Dursun P: Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature. World J Surg Oncol. 2008, 6: 53-PubMedCentralPubMed
507.
Frumovitz M, Levenback CF: Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park). 2008, 22: 529-536. discussion 538–539, 542–543
508.
Johann S, Klaeser B, Krause T, Mueller MD: Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer. Gynecol Oncol. 2008, 110: 324-328.PubMed
509.
Hampl M, Hantschmann P, Michels W, Hillemanns P: German multicenter study group: validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008, 111: 282-288.PubMed
510.
Levenback C, Tian C, Coleman R, Gold M, Fowler J, Judson P: Sentinel node (SN) biopsy in patients with vulvar cancer, the Gynecologic Oncology Group (GOG) experience. Ann Surg Oncol. 2008, 15 (S1): 28-
511.
van Dam P, Sonnemans H, van Dam PJ, Verkinderen L, Dirix LY: Sentinel node detection in patients with vaginal carcinoma. Gynecol Oncol. 2004, 92: 89-92.PubMed
512.
Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF: Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008, 108: 478-481.PubMed
513.
Verheijen RH, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P: Sentinel node detection in cervical cancer. Obstet Gynecol. 2000, 96: 135-138.PubMed
514.
Kamprath S, Possover M, Schneider A: Laparoscopic sentinel lymph node detection in patients with cervical cancer. Am J Obstet Gynecol. 2000, 182: 1648-PubMed
515.
Malur S, Krause N, Köhler C, Schneider A: Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol. 2001, 80: 254-257.PubMed
516.
Lantzsch T, Wolters M, Grimm J, Mende T, Buchmann J, Sliutz G, Koelbl H: Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer. 2001, 85: 791-794.PubMedCentralPubMed
517.
Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, Delpassand ES: Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002, 20: 688-693.PubMed
518.
Rhim CC, Park JS, Bae SN, Namkoong SE: Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci. 2002, 17: 507-511.PubMedCentralPubMed
519.
van Dam PA, Hauspy J, Vanderheyden T, Sonnemans H, Spaepen A, Eggenstein G, Dirix L, Verkinderen L: Intraoperative sentinel node identification with technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer. 2003, 13: 182-186.PubMed
520.
Lambaudie E, Collinet P, Narducci F, Sonoda Y, Papageorgiou T, Carpentier P, Leblanc E, Querleu D: Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol. 2003, 89: 84-87.PubMed
521.
Chung YA, Kim SH, Sohn HS, Chung SK, Rhim CC, Namkoong SE: Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging. 2003, 30: 1014-1017.PubMed
522.
Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E: Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003, 97: 3003-3009.PubMed
523.
Buist MR, Pijpers RJ, van Lingen A, van Diest PJ, Dijkstra J, Kenemans P, Verheijen RH: Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol. 2003, 90: 290-296.PubMed
524.
Pityñski K, Basta A, Opławski M, Przeszlakowski D, Hubalewska-Hoła A, Krysztopowicz W: [Lymph node mapping and sentinel node detection in carcinoma of the cervix, endometrium and vulva]. Ginekol Pol. 2003, 74: 830-835. [Polish]PubMed
525.
Plante M, Renaud MC, Têtu B, Harel F, Roy M: Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol. 2003, 91: 494-503.PubMed
526.
Hubalewska A, Sowa-Staszczak A, Huszno B, Markocka A, Pityñski K, Basta A, Opławski M, Basta P: Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer. Nucl Med Rev Cent East Eur. 2003, 6: 127-130.PubMed
527.
Martínez-Palones JM, Gil-Moreno A, Pérez-Benavente MA, Roca I, Xercavins J: Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol. 2004, 92: 845-850.PubMed
528.
Li B, Zhang WH, Liu L, Wu LY, Zhang R, Li N: Sentinel lymph node identification in patients with early stage cervical cancer undergoing radical hysterectomy and pelvic lymphadenectomy. Chin Med J (Engl). 2004, 117: 867-870.
529.
Wang HY, Sun JM, Tang J: [Sentinel lymph nodes detection in patients with cervical cancer undergoing radical hysterectomy]. Zhonghua Fu Chan Ke Za Zhi. 2004, 39: 7-9. [Chinese]PubMed
530.
Sheng XG, Li DP, Liu NF, Li QS, Tang L, Li HQ, Lu CH: [Clinical significance of sentinel lymph nodes detection in patients with early stage cervical cancer]. Zhonghua Fu Chan Ke Za Zhi. 2004, 39: 10-13. [Chinese]PubMed
531.
Barranger E, Cortez A, Commo F, Marpeau O, Uzan S, Darai E, Callard P: Histopathological validation of the sentinel node concept in cervical cancer. Ann Oncol. 2004, 15: 870-874.PubMed
532.
Pijpers R, Buist MR, van Lingen A, Dijkstra J, van Diest PJ, Teule GJ, Kenemans P, Verheijen RH: The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging. 2004, 31: 1479-1486.PubMed
533.
Niikura H, Okamura C, Akahira J, Takano T, Ito K, Okamura K, Yaegashi N: Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol. 2004, 94: 528-532.PubMed
534.
Paredes P, Vidal-Sicart S, García S, Pahisa J, Torné A, Ordi J, Fuertes S, Ortega M, Pons F: [Usefulness of the sentinel node in the treatment and staging of initial cervix cancer]. Rev Esp Med Nucl. 2004, 23: 253-258. [Spanish]PubMed
535.
Gil-Moreno A, Díaz-Feijoo B, Roca I, Puig O, Pérez-Benavente MA, Aguilar I, Martínez-Palones JM, Xercavins J: Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol. 2005, 96: 187-193.PubMed
536.
Angioli R, Palaia I, Cipriani C, Muzii L, Calcagno M, Gullotta G, Panici PB: Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol. 2005, 96: 504-509.PubMed
537.
Lin YS, Tzeng CC, Huang KF, Kang CY, Chia CC, Hsieh JF: Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int J Gynecol Cancer. 2005, 15: 273-277.PubMed
538.
Silva LB, Silva-Filho AL, Traiman P, Triginelli SA, de Lima CF, Siqueira CF, Barroso A, Rossi TM, Pedrosa MS, Miranda D, Melo JR: Sentinel node detection in cervical cancer with (99m)Tc-phytate. Gynecol Oncol. 2005, 97: 588-595.PubMed
539.
Roca I, Caresia AP, Gil-Moreno A, Pifarre P, Aguade-Bruix S, Castell-Conesa J, Martínez-Palones JM, Xercavins J: Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur J Nucl Med Mol Imaging. 2005, 32: 1210-1216.PubMed
540.
Rob L, Strnad P, Robova H, Charvat M, Pluta M, Schlegerova D, Hrehorcak M: Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol. 2005, 98: 281-288.PubMed
541.
Wydra D, Sawicki S, Wojtylak S, Bandurski T, Emerich J: Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases. Int J Gynecol Cancer. 2006, 16: 649-654.PubMed
542.
Kraft O, Sevcík L, Klát J, Koliba P, Curík R, Kríozvá H: Detection of sentinel lymph nodes in cervical cancer. A comparison of two protocols. Nucl Med Rev Cent East Eur. 2006, 9: 65-68.PubMed
543.
Bats AS, Clément D, Larousserie F, Lefrère-Belda MA, Faraggi M, Froissart M, Lécuru F: Sentinel lymph node biopsy improves staging in early cervical cancer. Gynecol Oncol. 2007, 105: 189-193.PubMed
544.
Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A: Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol. 2007, 105: 285-290.PubMed
545.
Kushner DM, Connor JP, Wilson MA, Hafez GR, Chappell RJ, Stewart SL, Hartenbach EM: Laparoscopic sentinel lymph node mapping for cervix cancer – a detailed evaluation and time analysis. Gynecol Oncol. 2007, 106: 507-512.PubMed
546.
Lavoué V, Bats AS, Rouzier R, Coutant C, Barranger E, Daraï E: Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer. Ann Surg Oncol. 2007, 14: 2654-2661.PubMed
547.
Sevcík L, Klát J, Gráf P, Koliba P, Curík R, Kraft O: [Sentinel node detection in early stage of cervical carcinoma using 99mTc-nanocolloid and blue dye]. Ceska Gynekol. 2007, 72: 120-125. [Czech]PubMed
548.
Lou HM, Lü WG, Xie X, Yang ZY, Ying Y, Xiao BW, Fang XH: [Sentinel lymph node detection and intra-operational diagnosis in patients with early stage cervical cancer]. Zhonghua Yi Xue Za Zhi. 2007, 87: 3353-3356. [Chinese]PubMed
549.
Altgassen C, Hertel H, Brandstädt A, Köhler C, Dürst M, Schneider A, AGO Study Group: Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. Clin Oncol. 2008, 26: 2943-2951.
550.
Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC: Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol. 2008, 111: 13-17.PubMed
551.
Levenback CF: Status of sentinel lymph nodes in cervical cancer. Gynecol Oncol. 2007, 107 (Suppl 1): S18-S19.PubMed
552.
Frumovitz M, Ramirez PT, Levenback CF: Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008, 110 (Suppl 2): S17-S20.PubMed
553.
Lande van de J, Torrenga B, Raijmakers PG, Hoekstra OS, van Baal MW, Brölmann HA, Verheijen RH: Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol. 2007, 106: 604-613.PubMed
554.
Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K: Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ. 2008, 178: 855-862.PubMedCentralPubMed
555.
Pelosi E, Arena V, Baudino B, Bellò M, Gargiulo T, Giusti M, Bottero A, Leo L, Armellino F, Palladin D, Bisi G: Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori. 2002, 88: S9-S10.PubMed
556.
Pelosi E, Arena V, Baudino B, Bellò M, Giusti M, Gargiulo T, Palladin D, Bisi G: Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun. 2003, 24: 971-975.PubMed
557.
Gargiulo T, Giusti M, Bottero A, Leo L, Brokaj L, Armellino F, Palladin L: Sentinel lymph node (SLN) laparoscopic assessment early stage in endometrial cancer. Minerva Ginecol. 2003, 55: 259-262.PubMed
558.
Fersis N, Gruber I, Relakis K, Friedrich M, Becker S, Wallwiener D, Wagner U: Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol. 2004, 25: 339-342.PubMed
559.
Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N: Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2004, 92: 669-674.PubMed
560.
Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E: Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol. 2004, 11: 344-349.PubMed
561.
Raspagliesi F, Ditto A, Kusamura S, Fontanelli R, Vecchione F, Maccauro M, Solima E: Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol. 2004, 191: 435-439.PubMed
562.
Lelièvre L, Camatte S, Le Frère-Belda MA, Kerrou K, Froissart M, Taurelle R, Vildé F, Lécuru F: [Sentinel lymph node biopsy in cervical and endometrial cancers: a feasibility study]. Bull Cancer. 2004, 91: 379-384. [French]PubMed
563.
Maccauro M, Lucignani G, Aliberti G, Villano C, Castellani MR, Solima E, Bombardieri E: Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging. 2005, 32: 569-574.PubMed
564.
Bats AS, Clément D, Larousserie F, Lefrère-Belda MA, Faraggi M, Froissart M, Lécuru F: [Is sentinel node biopsy feasible in endometrial cancer? Results in 26 patients]. J Gynecol Obstet Biol Reprod (Paris). 2005, 34: 768-774. [French]
565.
Dzvincuk P, Pilka R, Kudela M, Koranda P: [Sentinel lymph node detection using 99mTc-nanocolloid in endometrial cancer]. Ceska Gynekol. 2006, 71: 231-236. [Czech]PubMed
566.
Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF: Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007, 104: 100-103.PubMed
567.
Delaloye JF, Pampallona S, Chardonnens E, Fiche M, Lehr HA, De Grandi P, Delaloye AB: Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol. 2007, 106: 89-93.PubMed
568.
Niikura H, Okamoto S, Yoshinaga K, Nagase S, Takano T, Ito K, Yaegashi N: Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol. 2007, 105: 683-686.PubMed
569.
Delpech Y, Cortez A, Coutant C, Callard P, Uzan S, Darai E, Barranger E: The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007, 18: 1799-1803.PubMed
570.
Bats AS, Clément D, Larousserie F, Le Frère-Belda MA, Pierquet-Ghazzar N, Hignette C, Lécuru F: Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol. 2008, 97: 141-145.PubMed
571.
Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E: Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol. 2008, 15: 1523-1529.PubMed
572.
Perrone AM, Casadio P, Formelli G, Levorato M, Ghi T, Costa S, Meriggiola MC, Pelusi G: Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol. 2008, 111: 62-67.PubMed
573.
Clement D, Bats AS, Ghazzar-Pierquet N, Le Frere Belda MA, Larousserie F, Nos C, Lecuru F: Sentinel lymph nodes in endometrial cancer: is hysteroscopic injection valid?. Eur J Gynaecol Oncol. 2008, 29: 239-241.PubMed
574.
Khoury-Collado F, Abu-Rustum NR: Lymphatic mapping in endometrial cancer: a literature review of current techniques and results. Int J Gynecol Cancer. 2008,
575.
Gitsch E, Pateisky N, Schatten C: Diagnostic and intraoperative immunoscintigraphy in ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1989, 32: 33-37.PubMed
576.
Gitsch E, Pateisky N: Radio-immunoscintigraphy and intraoperative tumour detection by means of anti-tumour antibodies in patients with ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989, 3: 31-36.PubMed
577.
Pateisky N, Gitsch E: [Immunoscintigraphy and intraoperative tumor search in ovarian cancer]. Arch Gynecol Obstet. 1989, 245: 606-609. [German]PubMed
578.
Bell J, Mojzisik C, Hinkle G, Derman H, Schlom J, Martin E: Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe. Obstet Gynecol. 1990, 76: 607-611.PubMed
579.
Jäger W, Feistel H, Paterok EM, Ronay G, Tulusan AH, Wolf F, Lang N: Resection guided by antibodies (REGAJ): a diagnostic procedure during second-look operation in ovarian cancer patients. Br J Cancer Suppl. 1990, 10: 18-20.PubMed
580.
Krag DN, Haseman MK, Ford P, Smith L, Taylor MH, Schneider P, Goodnight JE: Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphy. J Surg Oncol. 1992, 51: 226-230.PubMed
581.
Ind TE, Granowska M, Britton KE, Morris G, Lowe DG, Hudson CN, Shepherd JH: Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe. Br J Cancer. 1994, 70: 1263-1266.PubMedCentralPubMed
582.
McIntosh DG, Colcher D, Seemayer T, Smith ML: The intraoperative detection of ovarian adenocarcinoma using radiolabeled CC49 monoclonal antibody and a hand-held gamma-detecting probe. Cancer Biother Radiopharm. 1997, 12: 287-294.PubMed
583.
Barranger E, Kerrou K, Petegnief Y, David-Montefiore E, Cortez A, Daraï E: Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol. 2005, 96: 241-244.PubMed
584.
Ahmed HU, Arya M, Minhas S: Dynamic sentinel lymph node biopsy in penile cancer. Expert Rev Anticancer Ther. 2006, 6: 963-967.PubMed
585.
Cabanas RM: An approach for the treatment of penile carcinoma. Cancer. 1977, 39: 456-466.PubMed
586.
Riveros M, Garcia R, Cabañas R: Lymphadenography of the dorsal lymphatics of the penis. Technique and results. Cancer. 1967, 20: 2026-2031.PubMed
587.
Perinetti E, Crane DB, Catalona WJ: Unreliability of sentinel lymph node biopsy for staging penile carcinoma. J Urol. 1980, 124: 734-735.PubMed
588.
Fowler JE: Sentinel lymph node biopsy for staging penile cancer. Urology. 1984, 23: 352-353.PubMed
589.
Wespes E, Simon J, Schulman CC: Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma?. Urology. 1986, 28: 278-279.PubMed
590.
Fosså SD, Hall KS, Johannessen NB, Urnes T, Kaalhus O: Cancer of the penis. Experience at the Norwegian Radium Hospital 1974-1985. Eur Urol. 1987, 13: 372-377.PubMed
591.
Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A: Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 1995, 154: 1999-2003.PubMed
592.
Wawroschek F, Vogt H, Bachter D, Weckermann D, Hamm M, Harzmann R: First experience with gamma probe guided sentinel lymph node surgery in penile cancer. Urol Res. 2000, 28: 246-249.PubMed
593.
Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, de Jong D, Nieweg OE: Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol. 2000, 163: 100-104.PubMed
594.
Valdés Olmos RA, Tanis PJ, Hoefnagel CA, Jansen L, Nieweg OE, Meinhardt W, Horenblas S: Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med. 2001, 28: 581-585.PubMed
595.
Akduman B, Fleshner NE, Ehrlich L, Klotz L: Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe. Urology. 2001, 58: 65-68.PubMed
596.
Benejam Gual JM, García-Miralles Grávalos R, Hidalgo Pardo F, Muñoz Vélez D, Hellín Hellín D, Lago Rodríguez J: [Usefulness of the dynamic sentinel node technique in patients with penile carcinoma]. Actas Urol Esp. 2001, 25: 409-414. [Spanish]PubMed
597.
Tanis PJ, Lont AP, Meinhardt W, Olmos RA, Nieweg OE, Horenblas S: Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol. 2002, 168: 76-80.PubMed
598.
Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE: Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol. 2003, 170: 783-786.PubMed
599.
Kroon BK, Horenblas S, Meinhardt W, Poel van der HG, Bex A, van Tinteren H, Valdés Olmos RA, Nieweg OE: Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol. 2005, 47: 601-606. discussion 606PubMed
600.
Perdonà S, Autorino R, De Sio M, Di Lorenzo G, Gallo L, Damiano R, D'Armiento M, Gallo A: Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study. Urology. 2005, 66: 1282-1286.PubMed
601.
Brennhovd B, Johnsrud K, Berner A, Bogsrud T, Waehre H, Giercksky KE, Axcrona K: Sentinel node procedure in low-stage/low-grade penile carcinomas. Scand J Urol Nephrol. 2006, 40: 204-207.PubMed
602.
Perdonà S, Autorino R, Gallo L, Di Lorenzo G, Cascini GL, Lastoria F, Marra L, De Sio M, Damiano R, Gallo A: Role of dynamic sentinel node biopsy in penile cancer: our experience. J Surg Oncol. 2006, 93: 181-185.PubMed
603.
Leijte JA, Kroon BK, Valdés Olmos RA, Nieweg OE, Horenblas S: Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol. 2007, 52: 170-177.PubMed
604.
Gonzaga-Silva LF, Tavares JM, Freitas FC, Tomas Filho ME, Oliveira VP, Lima MV: The isolated gamma probe technique for sentinel node penile carcinoma detection is unreliable. Int Braz J Urol. 2007, 33: 58-63. discussion 64–67PubMed
605.
Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, Eddings T, Tamboli P, Pettaway CA: Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol. 2007, 177: 2157-2161.PubMed
606.
Hernández-Toris N, Quintero-Becerra J, Gallegos-Hernández JF, Flores-Ojeda R, Alvarado-Cabrero I, Flores-López D, Pichardo-Romero P: [Lymphatic mapping and sentinel node biopsy in penis cancer. Feasibility study and preliminary report]. Cir Cir. 2007, 75: 87-91. [Spanish]PubMed
607.
Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA: Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int. 2007, 100: 561-565.PubMed
608.
Rubí S, Vidal-Sicar S, Ortega M, Doménech B, Lafuente S, Corral JM, Gelabert-Mas A: [Localization of sentinel node in squamous cell carcinoma of the penis. Initial experience]. Rev Esp Med Nucl. 2008, 27: 3-7. [Spanish]PubMed
609.
Heyns CF, Theron PD: Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes. BJU Int. 2008, 102: 305-309.PubMed
610.
Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R: The sentinel lymph node concept in prostate cancer – first results of gamma probe-guided sentinel lymph node identification. Eur Urol. 1999, 36: 595-600.PubMed
611.
Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R: Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol. 2001, 166: 1715-1719.PubMed
612.
Wengenmair H, Kopp J, Vogt H, Wawroschek F, Gröber S, Dorn R, Heidenreich P: [Sentinel lymph node diagnosis in prostatic carcinoma: II. Biokinetics and dosimetry of 99mTc-nanocolloid after intraprostatic injection]. Nuklearmedizin. 2002, 41: 102-107. [German]PubMed
613.
Vogt H, Wawroschek F, Wengenmair H, Wagner T, Kopp J, Dorn R, Gröber S, Heidenreich P: [Sentinel lymph node diagnosis in prostatic carcinoma: I: Method and clinical evaluation]. Nuklearmedizin. 2002, 41: 95-101. [German]PubMed
614.
Rudoni M, Sacchetti GM, Leva L, Inglese E, Monesi G, Minocci D, Frea B: Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori. 2002, 88: S16-S17.PubMed
615.
Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M, Graf G, Heidenreich P, Harzmann R: Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int. 2003, 70: 303-310.PubMed
616.
Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M: Validity of sentinel lymph node concept for patients with prostate cancer. J Urol. 2004, 171: 2268-2271.PubMed
617.
Egawa M, Fukuda M, Takashima H, Imao T, Namiki M: [Application of sentinel node navigation surgery to prostate cancer]. Gan To Kagaku Ryoho. 2005, 32: 117-120. JapanesePubMed
618.
Bastide C, Brenot-Rossi I, Garcia S, Dumas S, Anfossi E, Ragni E, Rossi D: [Feasibility and value of the isotope sentinel node mapping technique in prostate cancer]. Prog Urol. 2004, 14: 501-506. [French]PubMed
619.
Brenot-Rossi I, Bastide C, Garcia S, Dumas S, Esterni B, Pasquier J, Rossi D: Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging. 2005, 32: 635-640.PubMed
620.
Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G: Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2005, 173: 1943-1946.PubMed
621.
Silva N, Anselmi CE, Anselmi OE, Madke RR, Hunsche A, Souto JS, Souto CA, Sica FD, Pioner GT, Macalos EC, Hartmann AA, Lima MS: Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun. 2005, 26: 1081-1086.PubMed
622.
Corvin S, Schilling D, Eichhorn K, Hundt I, Hennenlotter J, Anastasiadis AG, Kuczyk M, Bares R, Stenzl A: Laparoscopic sentinel lymph node dissection – a novel technique for the staging of prostate cancer. Eur Urol. 2006, 49: 280-285.PubMed
623.
Weckermann D, Hamm M, Dorn R, Wagner T, Wawroschek F, Harzmann R: [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions]. Urologe A. 2006, 45: 723-727. [German]PubMed
624.
Häcker A, Jeschke S, Leeb K, Prammer K, Ziegerhofer J, Sega W, Langsteger W, Janetschek G: Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2006, 176: 2014-2018. discussion 2018–2019PubMed
625.
Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R: Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol. 2007, 51: 1549-1556. discussion 1556–1558PubMed
626.
Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE: Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol. 2007, 52: 126-132.PubMed
627.
Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R: Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol. 2007, 177: 916-920.PubMed
628.
Fukuda M, Egawa M, Imao T, Takashima H, Yokoyama K, Namiki M: Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol. 2007, 177: 1313-1317. discussion 1317PubMed
629.
Jeschke S, Beri A, Grüll M, Ziegerhofer J, Prammer P, Leeb K, Sega W, Janetschek G: Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol. 2008, 53: 126-132.PubMed
630.
Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C: Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging. 2008, 35: 32-38.PubMed
631.
Hautmann S, Beitz S, Naumann M, Lützen U, Seif C, Stübinger SH, Horst van der C, Braun PM, Leuschner I, Henze E, Jünemann KP: [Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population]. Urologe A. 2008, 47: 299-303. [German]PubMed
632.
Meinhardt W, Valdés Olmos RA, Poel van der HG, Bex A, Horenblas S: Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int. 2008, 102: 714-717.PubMed
633.
Badalament RA, Burgers JK, Petty LR, Mojzisik CM, Berens A, Marsh W, Hinkle GH, Martin EW: Radioimmunoguided radical prostatectomy and lymphadenectomy. Cancer. 1993, 71: 2268-2275.PubMed
634.
Anderson RS, Eifert B, Tartt S, King P: Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer. Urology. 2000, 56: 669xii-669xiv.
635.
Tanis PJ, Horenblas S, Valdés Olmos RA, Hoefnagel CA, Nieweg OE: Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging. 2002, 29: 670-673.PubMed
636.
Ohyama C, Chiba Y, Yamazaki T, Endoh M, Hoshi S, Arai Y: Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor. J Urol. 2002, 168: 1390-1395.PubMed
637.
Satoh M, Ito A, Kaiho Y, Nakagawa H, Saito S, Endo M, Ohyama C, Arai Y: Intraoperative, radio-guided sentinel lymph node mapping in laparoscopic lymph node dissection for Stage I testicular carcinoma. Cancer. 2005, 103: 2067-2072.PubMed
638.
639.
Sherif A, De La Torre M, Malmström PU, Thörn M: Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol. 2001, 166: 812-815.PubMed
640.
Liedberg F, Chebil G, Davidsson T, Malmström PU, Sherif A, Thörn M, De La Torre M, Månsson W: [Bladder cancer and the sentinel node concept]. Aktuelle Urol. 2003, 34: 115-118. [German]PubMed
641.
Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W: Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol. 2006, 175: 84-88. discussion 88–89PubMed
642.
Sherif A, Garske U, de la Torre M, Thörn M: Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol. 2006, 50: 83-91.PubMed
643.
Avital S, Hitchcock CL, Baratz M, Haddad R, Skornick Y, Schneebaum S: Localization of monoclonal antibody CC49 in colonic metastasis from renal cell carcinoma. Eur J Surg Oncol. 1998, 24: 149-151.PubMed
644.
Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ, Oettgen HF, Old LJ: Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol. 1993, 11: 738-750.PubMed
645.
Uemura H, Nakagawa Y, Yoshida K, Saga S, Yoshikawa K, Hirao Y, Oosterwijk E: MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer. 1999, 81: 741-746.PubMedCentralPubMed
646.
Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P: Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol. 2007, 8: 304-310.PubMed
647.
Woolfenden JM, Nevin WS, Barber HB, Donahue DJ: Lung cancer detection using a miniature sodium iodide detector and cobalt-57 bleomycin. Chest. 1984, 85: 84-88.PubMed
648.
Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR, Perlman RM, Fry WA: Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000, 70: 384-389.PubMed
649.
Nomori H, Horio H, Naruke T, Orikasa H, Yamazaki K, Suemasu K: Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002, 124: 486-492.PubMed
650.
Liptay MJ, Grondin SC, Fry WA, Pozdol C, Carson D, Knop C, Masters GA, Perlman RM, Watkin W: Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol. 2002, 20: 1984-1988.PubMed
651.
Schmidt FE, Woltering EA, Webb WR, Garcia OM, Cohen JE, Rozans MH: Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg. 2002, 74: 870-874. discussion 874–875PubMed
652.
Sugi K, Fukuda M, Nakamura H, Kaneda Y: Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer. 2003, 39: 37-40.PubMed
653.
Melfi FM, Chella A, Menconi GF, Givigliano F, Boni G, Mariani G, Sbragia P, Angeletti CA: Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer. Eur J Cardiothorac Surg. 2003, 23: 214-220.PubMed
654.
Lardinois D, Brack T, Gaspert A, Spahr T, Schneiter D, Steinert HC, Weder W: Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer. Eur J Cardiothorac Surg. 2003, 23: 824-827.PubMed
655.
Sugi K, Kaneda Y, Sudoh M, Sakano H, Hamano K: Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer. J Thorac Cardiovasc Surg. 2003, 126: 568-573.PubMed
656.
Sugi K, Kitada K, Murakami T, Matsuda E, Hirazawa K, Azuma T, Umemori Y: [Sentinel node biopsy for staging of small peripheral lung cancer]. Kyobu Geka. 2004, 57: 14-17. [Japanese]PubMed
657.
Liptay MJ: Sentinel node mapping in lung cancer. Ann Surg Oncol. 2004, 11: 271S-274S.PubMed
658.
Ueda K, Suga K, Kaneda Y, Sakano H, Tanaka T, Hayashi M, Li TS, Hamano K: Radioisotope lymph node mapping in nonsmall cell lung cancer: can it be applicable for sentinel node biopsy?. Ann Thorac Surg. 2004, 77: 426-430.PubMed
659.
Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K: In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissection. Lung Cancer. 2004, 46: 49-55.PubMed
660.
Tiffet O, Nicholson AG, Khaddage A, Prévot N, Ladas G, Dubois F, Goldstraw P: Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest. 2005, 127: 443-448.PubMed
661.
Atinkaya C, Ozlem Küçük N, Koparal H, Aras G, Sak SD, Ozdemir N: Mediastinal intraoperative radioisotope sentinel lymph node mapping in non-small-cell lung cancer. Nucl Med Commun. 2005, 26: 717-720.PubMed
662.
Rzyman W, Hagen OM, Dziadziuszko R, Kobierska-Gulida G, Karmolinski A, Lothe IM, Babovic A, Murawski M, Paleczka W, Jastrzebski T, Kopacz A, Jassem J, Lass P, Skokowski J: Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients. Ann Thorac Surg. 2006, 82: 237-242.PubMed
663.
Nomori H, Ikeda K, Mori T, Kobayashi H, Iwatani K, Kawanaka K, Shiraishi S, Kobayashi T: Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007, 133: 780-785.PubMed
664.
Nomori H, Ikeda K, Mori T, Shiraishi S, Kobayashi H, Iwatani K, Kawanaka K, Kobayashi T: Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system. J Thorac Cardiovasc Surg. 2007, 134: 182-187.PubMed
665.
Meyer A, Cheng C, Antonescu C, Pezzetta E, Bischof-Delaloye A, Ris HB: Successful migration of three tracers without identification of sentinel nodes during intraoperative lymphatic mapping for non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2007, 6: 214-218.PubMed
666.
Di Lieto E, Gallo G, Scarpati VD, Di Tommaso P, Carpenito A, Perrone A: [Lymph node sentinel detection in lung resection for non small cell lung cancer: our experience]. Recenti Prog Med. 2007, 98: 327-328. [Italian]PubMed
667.
Melfi FM, Lucchi M, Davini F, Viti A, Fontanini G, Boldrini L, Boni G, Mussi A: Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction. Eur J Cardiothorac Surg. 2008, 34: 181-186.PubMed
668.
Sugi K, Kobayashi S, Yagi R, Matsuoka T: Usefulness of sentinel lymph node biopsy for the detection of lymph node micrometastasis in early lung cancer. Interact Cardiovasc Thorac Surg. 2008, 7: 913-915.PubMed
669.
Liptay MJ: Sentinel node mapping in lung cancer: the Holy Grail?. Ann Thorac Surg. 2008, 85: S778-S779.PubMed
670.
Grazia M, Bini A, Stella F, Pagani D, Bazzocchi R: Radioimmunoguided surgery and intraoperative lung cancer staging. Semin Surg Oncol. 1998, 15: 215-219.PubMed
671.
Mansi L, Di Lieto E, Rambaldi PF, Bergaminelli C, Fallanca F, Vicidomini G, Cuccurullo V, Mancusi R: [Preliminary experience with radioimmuno-guided surgery of primary neoplasms of the lung]. Minerva Chir. 1998, 53: 369-372.PubMed
672.
Wang YQ, Sun YE, Zhang JM, Liu X: [Clinical practice of 99mTc-peplimycin imaging and radio guided surgery for lung neoplasms]. Ai Zheng. 2003, 22: 749-752.PubMed
673.
Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T: Radioguided detection of lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg. 2006, 82: 1815-1820.PubMed
674.
Moffatt-Bruce SD, Povoski SP, Sharif S, Hall NC, Ross P, Johnson MA, Martin EW: A novel approach to positron emission tomography in lung cancer. Ann Thorac Surg. 2008, 86: 1355-1357.PubMed
675.
Chella A, Lucchi M, Ambrogi MC, Menconi G, Melfi FM, Gonfiotti A, Boni G, Angeletti CA: A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Eur J Cardiothorac Surg. 2000, 18: 17-21.PubMed
676.
Boni G, Bellina CR, Grosso M, Lucchi M, Manca G, Ambrogi MC, Volterrani D, Menconi G, Melfi FM, Gonfiotti A, Davini F, Angeletti CA, Bianchi R, Chella A: Gamma probe-guided thoracoscopic surgery of small pulmonary nodules. Tumori. 2000, 86: 364-366.PubMed
677.
Sortini D, Feo CV, Carrella G, Bergossi L, Soliani G, Carcoforo P, Pozza E, Sortini A: Thoracoscopic localization techniques for patients with a single pulmonary nodule and positive oncological anamnesis: a prospective study. J Laparoendosc Adv Surg Tech A. 2003, 13: 371-375.PubMed
678.
Daniel TM, Altes TA, Rehm PK, Williams MB, Jones DR, Stolin AV, Gay SB: A novel technique for localization and excisional biopsy of small or ill-defined pulmonary lesions. Ann Thorac Surg. 2004, 77: 1756-1762. discussion 1762PubMed
679.
Sortini D, Feo CV, Carcoforo P, Carrella G, Pozza E, Liboni A, Sortini A: Thoracoscopic localization techniques for patients with solitary pulmonary nodule and history of malignancy. Ann Thorac Surg. 2005, 79: 258-262. discussion 262PubMed
680.
Stiles BM, Altes TA, Jones DR, Shen KR, Ailawadi G, Gay SB, Olazagasti J, Rehm PK, Daniel TM: Clinical experience with radiotracer-guided thoracoscopic biopsy of small, indeterminate lung nodules. Ann Thorac Surg. 2006, 82: 1191-1196. discussion 1196–1197PubMed
681.
Davini F, Gonfiotti A, Vaggelli L, De Francisci A, Gigli P, Janni A: Thoracoscopic localization techniques for patients with solitary pulmonary nodule: radioguided surgery versus hookwire localization. J Cardiovasc Surg (Torino). 2006, 47: 355-359.
682.
Gonfiotti A, Davini F, Vaggelli L, De Francisci A, Caldarella A, Gigli PM, Janni A: Thoracoscopic localization techniques for patients with solitary pulmonary nodule: hookwire versus radio-guided surgery. Eur J Cardiothorac Surg. 2007, 32: 843-847.PubMed
683.
Grogan EL, Jones DR, Kozower BD, Simmons WD, Daniel TM: Identification of small lung nodules: technique of radiotracer-guided thoracoscopic biopsy. Ann Thorac Surg. 2008, 85: S772-S777.PubMed
684.
Adams S, Baum RP: Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med. 2000, 44: 59-67.PubMed
685.
Gulec SA, Mountcastle TS, Frey D, Cundiff JD, Mathews E, Anthony L, O'Leary JP, Boudreaux JP: Cytoreductive surgery in patients with advanced-stage carcinoid tumors. Am Surg. 2002, 68: 667-671. discussion 671–672PubMed
686.
Åkerström G, Hellman P, Hessman O, Osmak L: Management of midgut carcinoids. J Surg Oncol. 2005, 89: 161-169.PubMed
687.
Gulec SA, Baum R: Radioguided Surgery in Neuroendocrine Tumors. J Surg Oncol. 2007, 96: 309-315.PubMed
688.
Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ: Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993, 20: 716-731.PubMed
689.
Schillaci O, Spanu A, Scopinaro F, Flachi A, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G: Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2003, 44: 359-368.PubMed
690.
Yüksel M, Eziddin S, Ladwein E, Haas S, Biersack HJ: 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET. Ann Nucl Med. 2005, 19: 611-615.PubMed
691.
Åkerströom G, Makridis C, Johansson H: Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol. 1991, 30: 547-553.
692.
Norton JA: Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol. 1999, 10: 182-184.PubMed
693.
Öhrvall U, Westlin J, Nilsson S, Juhlin C, Rastad J, Lundqvist H, Åkerström G: Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer. 1997, 80: 2490-2494.PubMed
694.
Adams S, Baum R, Hertel A, Wenisch H, Staib-Sebler E, Herrmann G, Encke A, Hör G: Intraoperative Gamma Probe Detection of Neuroendocrine Tumors. J Nucl Med. 1998, 39: 1155-1160.PubMed
695.
Pelaez N, Busquets J, Ortega M, Martinez Miralles E, Puig F, Miret M, Munne A, Grande L: Intraoperative gamma probe detection of lymph node recurrence of insulinoma. J Surg Oncol. 2005, 91: 209-211.PubMed
696.
Schirmer WJ, O'Dorisio TM, Schirmer TP, Mojzisik CM, Hinkle GH, Martin EW: Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe. Surgery. 1993, 114: 745-751. discussion 751–752PubMed
697.
Benevento A, Dominioni L, Carcano G, Dionigi R: Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe. Semin Surg Oncol. 1998, 15: 239-244.PubMed
698.
Hubalewska-Dydejczyk A, Kulig J, Szybinski P, Mikolajczak R, Pach D, Sowa-Staszczak A, Fröss-Baron K, Huszno B: Radio-guided surgery with the use of [99mTc-EDDA/HYNIC] octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract. Eur J Nucl Med Mol Imaging. 2007, 34: 1545-1555.PubMed
699.
Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA: Neuroendocrine hepatic metastases: does aggressive management improve survival?. Ann Surg. 2005, 241: 776-783. discussion 783–785PubMedCentralPubMed
700.
Maecke HR, Hofmann M, Haberkorn U: (68)Ga-labeled peptides in tumor imaging. J Nucl Med. 2005, 46 (Suppl 1): 172S-178S.PubMed
701.
Arbizu J, Rodriguez-Fraile M, Dominguez-Prado I, Garrastachu P, Rotellar F, Sangro B, Richter JA: Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours. Eur J Nucl Med Mol Imaging. 2008, 35: 1577-PubMed
702.
Mansi L, Rambaldi PF, Panza N, Esposito D, Esposito V, Pastore V: Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. Eur J Endocrinol. 1997, 137: 688-690.PubMed
703.
Grossrubatscher E, Vignati F, Dalino P, Possa M, Belloni PA, Vanzulli A, Bramerio M, Marocchi A, Rossetti O, Zurleni F, Loli P: Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome. J Endocrinol Invest. 2005, 28: 72-78.PubMed
704.
Martinez DA, O'Dorisio MS, O'Dorisio TM, Qualman SJ, Caniano DA, Teich S, Besner GE, King DR: Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression. J Pediatr Surg. 1995, 30: 1580-1589.PubMed
705.
Heij HA, Rutgers EJ, de Kraker J, Vos A: Intraoperative search for neuroblastoma by MIBG and radioguided surgery with the gamma detector. Med Pediatr Oncol. 1997, 28: 171-174.PubMed
706.
Martelli H, Ricard M, Larroquet M, Wioland M, Paraf F, Fabre M, Josset P, Helardot PG, Gauthier F, Terrier-Lacombe MJ, Michon J, Harmann O, Tabone MD, Patte C, Lumbroso J, Gruner M: Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabelled metaiodobenzylguanidine. Surgery. 1998, 123: 51-57.PubMed
707.
Iagaru A, Peterson D, Quon A, Dutta S, Twist C, Daghighian F, Gambhir SS, Albanese C: 123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. Mol Imaging Biol. 2008, 10: 19-23.PubMed
708.
Hoefnagel CA: Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med. 1994, 21: 561-581.PubMed
709.
Fasshauer H, Freundlieb O, Dostal G, Littmann K, Tharandt L, Strötges MW: [Intraoperative localization of pheochromocytoma metastases using 131I-meta-benzylguanidine]. Nuklearmedizin. 1984, 23: 203-205. [German]PubMed
710.
Proye CA, Carnaille BM, Flament JB, Hossein-Foucher CA, Lecouffe PP, Marchandise XM, Lennquist S: Intraoperative radionuclear 125I-labeled metaiodobenzylguanidine scanning of pheochromocytomas and metastases. Surgery. 1992, 111: 634-639.PubMed
711.
Ricard M, Tenenbaum F, Schlumberger M, Travagli JP, Lumbroso J, Revillon Y, Parmentier C: Intraoperative detection of pheochromocytoma with iodine-125 labelled metaiodobenzylguanidine: a feasibility study. Eur J Nucl Med. 1993, 20: 426-430.PubMed
712.
Blazer DG, Sabel MS, Sondak VK: Is there a role for sentinel lymph node biopsy in the management of sarcoma?. Surg Oncol. 2003, 12: 201-206.PubMed
713.
Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI: Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000, 35: 961-964.PubMed
714.
McMulkin HM, Yanchar NL, Fernandez CV, Giacomantonio C: Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int. 2003, 19: 453-456.PubMed
715.
Al-Refaie WB, Ali MW, Chu DZ, Paz IB, Blair SL: Clear cell sarcoma in the era of sentinel lymph node mapping. J Surg Oncol. 2004, 87: 126-129.PubMed
716.
Picciotto F, Zaccagna A, Derosa G, Pisacane A, Puiatti P, Colombo E, Dardano F, Ottinetti A: Clear cell sarcoma (malignant melanoma of soft parts) and sentinel lymph node biopsy. Eur J Dermatol. 2005, 15: 46-48.PubMed
717.
Seal A, Tse R, Wehrli B, Hammond A, Temple CL: Sentinel node biopsy as an adjunct to limb salvage surgery for epithelioid sarcoma of the hand. World J Surg Oncol. 2005, 3: 41-PubMedCentralPubMed
718.
van Akkooi AC, Verhoef C, van Geel AN, Kliffen M, Eggermont AM, de Wilt JH: Sentinel node biopsy for clear cell sarcoma. Eur J Surg Oncol. 2006, 32: 996-999.PubMed
719.
Albores-Zúñiga O, Padilla-Rosciano AE, Martínez-Said H, Cuéllar-Hubbe M, Ramírez-Bollas J: [Clear cell sarcoma and sentinel lymph node biopsy. Case report and literature review]. Cir Cir. 2006, 74: 121-125. [Spanish]PubMed
720.
Tunn PU, Andreou D, Illing H, Fleige B, Dresel S, Schlag PM: Sentinel node biopsy in synovial sarcoma. Eur J Surg Oncol. 2008, 34: 704-707.PubMed
721.
Kayton ML, Delgado R, Busam K, Cody HS, Athanasian EA, Coit D, La Quaglia MP: Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer. 2008, 112: 2052-2059.PubMed
722.
De Corti F, Dall'igna P, Bisogno G, Casara D, Rossi CR, Foletto M, Alaggio R, Carli M, Cecchetto G: Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009, 52: 51-54.PubMed
723.
Vilela Filho O, Carneiro Filho O: Gamma probe-assisted brain tumor microsurgical resection: a new technique. Arq Neuropsiquiatr. 2002, 60: 1042-1047.PubMed
724.
Kojima T, Kumita S, Yamaguchi F, Mizumura S, Kitamura T, Kumazaki T, Teramoto A: Radio-guided brain tumorectomy using a gamma detecting probe and a mobile solid-state gamma camera. Surg Neurol. 2004, 61: 229-238. discussion 238PubMed
725.
Gay E, Vuillez JP, Palombi O, Brard PY, Bessou P, Passagia JG: Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. Neurosurgery. 2005, 57 (1 Suppl): 107-112. discussion 112–113PubMedCentralPubMed
726.
Serrano J, Rayo JI, Infante JR, Domínguez ML, Lorenzana L, Porras JL, Cabezudo JM, García-Bernardo L, Sánchez-Sánchez R: [Radioguided neurosurgery: a novel application of nuclear medicine]. Rev Esp Med Nucl. 2006, 25: 184-187. [Spanish]PubMed
727.
Bhanot Y, Rao S, Parmeshwaran RV: Radio-guided neurosurgery (RGNS): early experience with its use in brain tumour surgery. Br J Neurosurg. 2007, 21: 382-388.PubMed
728.
Ghelman B, Thompson FM, Arnold WD: Intraoperative radioactive localization of an osteoid-osteoma. case report. J Bone Joint Surg Am. 1981, 63: 826-827.PubMed
729.
Colton CL, Hardy JG: Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. Technical note. J Bone Joint Surg Am. 1983, 65: 1019-1022.PubMed
730.
Harcke HT, Conway JJ, Tachdjian MO, Dias LS, Noble HB, MacEwen GD, Weiss S: Scintigraphic localization of bone lesions during surgery. Skeletal Radiol. 1985, 13: 211-216.PubMed
731.
Lacheretz M, Herbaux B, Hossein-Foucher C, Lecouffe P, Richir M: [Peroperative isotopic detection in the treatment of osteoid osteoma in children]. Chirurgie. 1989, 115: 413-416. [French]PubMed
732.
Todd BD, Godfrey LW, Bodley RN: Intraoperative radioactive localization of an osteoid osteoma: a useful variation in technique. Br J Radiol. 1989, 62: 187-189.PubMed
733.
De Boeck H, Casteleyn PP, Bossuyt A, Jacobs A: Intraoperative radioactive localization of small bone tumours. Int Orthop. 1992, 16: 172-175.PubMed
734.
Kirchner B, Hillmann A, Lottes G, Sciuk J, Bartenstein P, Winkelmann W, Schober O: Intraoperative, probe-guided curettage of osteoid osteoma. Eur J Nucl Med. 1993, 20: 609-613.PubMed
735.
Wioland M, Sergent-Alaoui A: Didactic review of 175 radionuclide-guided excisions of osteoid osteomas. Eur J Nucl Med. 1996, 23: 1003-1011.PubMed
736.
D'Errico G, Rosa MA, Soluri A, Scafè R, Galli M, Chiarini S, Burgio N, Schiaratura A, Massa R, Scopinaro F: Radioguided biopsy of osteoid osteoma: usefulness of imaging probe. Tumori. 2002, 88: S30-S32.PubMed
737.
Tse WL, Hung LK, Law B, Ho PC: Enhanced localization of osteoid osteoma with radiolabeling and intraoperative gamma counter guidance: a case report. J Hand Surg [Am]. 2003, 28: 699-703.
738.
Kettunen JS, Mäkelä EA, Kauppinen TA: Gamma probe localization in the surgical treatment of osteoid osteoma. Scand J Surg. 2003, 92: 224-226.PubMed
739.
Matejka J, Záhlava J: [Vertebral osteoid osteoma – peroperative detection of its nidus using a surgical gamma probe]. Acta Chir Orthop Traumatol Cech. 2003, 70: 187-190. [Czech]PubMed
740.
Etchebehere M, Etchebehere EC, Reganin LA, Amstalden EM, Cliquet A, Camargo EE: Intraoperative localization of an osteoid-osteoma using a gamma probe. Int Orthop. 2004, 28: 379-383.PubMedCentralPubMed
741.
Van Royen BJ, Baayen JC, Pijpers R, Noske DP, Schakenraad D, Wuisman PI: Osteoid osteoma of the spine: a novel technique using combined computer-assisted and gamma probe-guided high-speed intralesional drill excision. Spine. 2005, 30: 369-373.PubMed
742.
Pratali R, Zuiani G, Inada M, Hanasilo C, Reganin L, Etchebehere E, Etchebehere M: Open resection of osteoid osteoma guided by a gamma-probe. Int Orthop. 2008,
743.
Harvey WC, Lancaster JL: Technical and clinical characteristics of a surgical biopsy probe. J Nucl Med. 1981, 22: 184-186.PubMed
744.
Krag DN, Ford PV, Patel M, Schneider PD, Goodnight JE: A simplified technique to resect abnormal bony radiolocalizations using a gamma counter. Surg Oncol. 1992, 1: 371-377.PubMed
745.
Adams S, Hovy L, Baum RP, Adams M, Maul FD, Kahla-Witzsch H, Zichner L, Jonas D, Hor G: [Intraoperative localization of metastases with a hand-held gamma probe]. Nuklearmedizin. 1995, 34: 161-164. [German]PubMed
746.
Robinson LA: Radioisotope-guided surgical biopsy of suspected osseous metastases. Cancer Control. 1997, 4: 516-522.PubMed
747.
Robinson LA, Preksto D, Muro-Cacho C, Hubbell DS: Intraoperative gamma probe-directed biopsy of asymptomatic suspected bone metastases. Ann Thorac Surg. 1998, 65: 1426-1432.PubMed
748.
Albert GD, Alex JC, Krag DN, Weinberg DA: Gamma probe localization of cranial bone lesions. Ophthal Plast Reconstr Surg. 1999, 15: 470-472.PubMed
749.
Fernandes DS, Aye RW, Garnett DJ, Denny J: Target-specific rib biopsy using the gamma probe. Am J Surg. 2000, 179: 389-390.PubMed
750.
Uppot RN, Gheyi VK, Panasuk B, Sagar VV: Intraoperative gamma probe directed rib resection. Del Med J. 2000, 72: 385-388.PubMed
751.
van Mesdag T, Gommans GM, de Waard JW: [Radionuclide-guided minimally invasive rib biopsy for metastases]. Ned Tijdschr Geneeskd. 2002, 146: 1539-1542. [Dutch]PubMed
752.
Axelsson CK, Nielsen BP, Graff J: Radioisotope-guided surgical biopsy of costal metastases in breast cancer patients. Scand J Surg. 2002, 91: 333-335.PubMed
753.
Thurman SA, Robinson LA, Ahmad N, Pow-Sang JM, Lockhart JL, Seigne J: Investigation of the safety and accuracy of intraoperative gamma probe directed biopsy of bone scan detected rib abnormalities in prostatic adenocarcinoma. J Urol. 2003, 169: 1341-1344.PubMed
754.
Sodha S, Nagda S, Lackman RD, Donthineni R: Gamma probe assisted biopsy of suspected metastatic rib lesions. Clin Orthop Relat Res. 2004, 422: 186-189.PubMed
755.
Andrade RS, Blondet JJ, Kast T, Jessurun J, Maddaus MA: Evaluation of isolated rib lesions with radionuclide-guided biopsy. Ann Thorac Surg. 2008, 86: 1111-1114.PubMed
756.
Schattner A, Cohen A, Wolfson L, Melloul M: Unexplained systemic symptoms and Gallium-67-guided decisions. Am J Med Sci. 2001, 321: 198-200.PubMed
757.
Burdine J, Joyce LD, Plunkett MB, Inampudi S, Kaye MG, Dunn DH: Feasibility and value of video-assisted thoracoscopic surgery wedge excision of small pulmonary nodules in patients with malignancy. Chest. 2002, 122: 1467-1470.PubMed
758.
Stehlin JS, Clark RL, Dewey WC: Continuous monitoring of leakage during regional perfusion. Arch Surg. 1961, 83: 943-949.PubMed
759.
Sardi A, Minton JP, Mojzisik C, Nieroda CA, Ferrara PJ, Hinkle GH, Thurston MO, Martin EW: The use of a hand-held gamma detector improves the safety of isolated limb perfusion. J Surg Oncol. 1989, 41: 172-176.PubMed
760.
Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P: [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities]. Langenbecks Arch Chir. 1990, 375: 208-213. [German]PubMed
761.
Sprenger HJ, Markwardt J, Schlag PM: [Quantitative radionuclide leakage control during isolated limb perfusion]. Nuklearmedizin. 1994, 33: 248-253. [German]PubMed
762.
Barker WC, Andrich MP, Alexander HR, Fraker DL: Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med. 1995, 22: 1242-1248.PubMed
763.
Sandrock D, Horst F, Gatzemeier W, Ghorbani M, Rauschecker H, Munz DL, Emrich D: Leakage measurement during selective limb perfusion using a gamma probe. Eur J Nucl Med. 1996, 23: 534-538.PubMed
764.
Daryanani D, Komdeur R, Ter Veen J, Nijhuis PH, Piers DA, Hoekstra HJ: Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol. 2001, 8: 566-572.PubMed
765.
van Ginkel RJ, Limburg PC, Piers DA, Koops HS, Hoekstra HJ: Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Ann Surg Oncol. 2002, 9: 355-363.PubMed
766.
Casara D, Rubello D, Pilati PL, Scalerta R, Foletto M, Rossi CR: A simplified procedure for continuous intraoperative external monitoring of systemic leakage during isolated limb perfusion. Tumori. 2002, 88: S61-S63.PubMed
767.
Casara D, Rubello D, Pilati P, Scalerta R, Foletto M, Rossi CR: Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mTc-HSA. Nucl Med Commun. 2004, 25: 61-66.PubMed
768.
Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW: Bringing advanced medical imaging into the operative arena could revolutionize the surgical care of cancer patients. Expert Rev Med Devices. 2008, 5: 663-667.PubMed
Metadata
Title
A comprehensive overview of radioguided surgery using gamma detection probe technology
Publication date
01-12-2009
Published in
World Journal of Surgical Oncology / Issue 1/2009
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-7-11

Other articles of this Issue 1/2009

World Journal of Surgical Oncology 1/2009 Go to the issue

Research

Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study

Case report

Spontaneous regression in alveolar soft part sarcoma: case report and literature review

Case report

Intraductal and invasive adenocarcinoma of duct of Luschka, mimicking chronic cholecystitis and cholelithiasis

Case report

Novel deployment of a covered duodenal stent in open surgery to facilitate closure of a malignant duodenal perforation

Research

Diagnosis and management of retroperitoneal ancient schwannomas

Case report

Gastric outlet obstruction due to adenocarcinoma in a patient with Ataxia-Telangiectasia syndrome: a case report and review of the literature